col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


1143 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Nature Communications
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―11 SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023 Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana S. Gonzalez-Reiche, et al. (+25)
2 [GO] 2024―Jul―08 Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England Emma Copland, Martina Patone, Defne Saatci, Lahiru Handunnetthi, Jennifer Hirst, David P. J. Hunt, et al. (+7)
3 [GO] 2024―Jul―07 Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19 Lucile P. A. Neyton, Ravi K. Patel, Aartik Sarma, K. Mark Ansel, Stephanie Christenson, Michael Adkisson, et al. (+77)
4 [GO] 2024―Jul―03 Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective Yuexiu Zhang, Michelle Chamblee, Jiayu Xu, Panke Qu, Mohamed M. Shamseldin, Sung J. Yoo, et al. (+17)
5 [GO] 2024―Jul―03 A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases Zaolan Liang, Xia Lin, Lihong Sun, Kimberly M. Edwards, Wenjun Song, Hailiang Sun, et al. (+21)
6 [GO] 2024―Jul―02 Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2 Huanyu Z. Li, Ashley C. W. Pike, Irina Lotsaris, Gamma Chi, Jesper S. Hansen, Sarah C. Lee, et al. (+13)
7 [GO] 2024―Jun―29 COVID-19 vaccination and major cardiovascular and haematological adverse events in Abu Dhabi: retrospective cohort study Marco A. F. Pimentel, Maaz Shaikh, Muna Al Safi, Yousuf Naqvi, Shadab Khan
8 [GO] 2024―Jun―28 A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, Stephen J. Polyak, Judith M. White, Joshua T. Schiffer
9 [GO] 2024―Jun―24 Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification Koen B. Pouwels, David W. Eyre, Thomas House, Ben Aspey, Philippa C. Matthews, Nicole Stoesser, et al. (+72)
10 [GO] 2024―Jun―20 Importations of SARS-CoV-2 lineages decline after nonpharmaceutical interventions in phylogeographic analyses Sama Goliaei, Mohammad-Hadi Foroughmand-Araabi, Aideen Roddy, Ariane Weber, Sanni Översti, Denise Kühnert, Alice C. McHardy
11 [GO] 2024―Jun―19 Effectiveness of COVID-19 vaccines against severe COVID-19 among patients with cancer in Catalonia, Spain Felippe Lazar Neto, Núria Mercadé-Besora, Berta Raventós, Laura Pérez-Crespo, Gilberto Castro Junior, Otavio T. Ranzani, Talita Duarte-Salles
12 [GO] 2024―Jun―15 A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses Yingdan Wang, Aihua Hao, Ping Ji, Yunping Ma, Zhaoyong Zhang, Jiali Chen, et al. (+12)
13 [GO] 2024―Jun―13 Potential pandemic risk of circulating swine H1N2 influenza viruses Valerie Le Sage, Nicole C. Rockey, Andrea J. French, Ryan McBride, Kevin R. McCarthy, Lora H. Rigatti, et al. (+14)
14 [GO] 2024―Jun―11 Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling Nell Saunders, Blandine Monel, Nadège Cayet, Lorenzo Archetti, Hugo Moreno, Alexandre Jeanne, et al. (+5)
15 [GO] 2024―Jun―08 Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12-17 years following SARS-CoV-2 Omicron infection: A target trial emulation Carlos K. H. Wong, Kristy T. K. Lau, Ivan C. H. Au, Sophelia H. S. Chan, Eric H. Y. Lau, Benjamin J. Cowling, Gabriel M. Leung
16 [GO] 2024―May―31 The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England Thomas Ward, Martyn Fyles, Alex Glaser, Robert S. Paton, William Ferguson, Christopher E. Overton
17 [GO] 2024―May―31 Nanoscale cellular organization of viral RNA and proteins in SARS-CoV-2 replication organelles Leonid Andronov, Mengting Han, Yanyu Zhu, Ashwin Balaji, Anish R. Roy, Andrew E. S. Barentine, et al. (+4)
18 [GO] 2024―May―28 Crykey: Rapid identification of SARS-CoV-2 cryptic mutations in wastewater Yunxi Liu, Nicolae Sapoval, Pilar Gallego-García, Laura Tomás, David Posada, Todd J. Treangen, Lauren B. Stadler
19 [GO] 2024―May―27 Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England Emma Copland, Martina Patone, Defne Saatci, Lahiru Handunnetthi, Jennifer Hirst, David P. J. Hunt, et al. (+7)
20 [GO] 2024―May―27 Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan Yujin Choi, Hyeon Jin Kim, Jaeyu Park, Myeongcheol Lee, Sunyoung Kim, Ai Koyanagi, et al. (+6)
21 [GO] 2024―May―23 Compound mortality impacts from extreme temperatures and the COVID-19 pandemic Y. T. Eunice Lo, Dann M. Mitchell, Antonio Gasparrini
22 [GO] 2024―May―22 Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany, Casper Rokx, Corine Geurtsvankessel, Grigorios Papageorgiou, et al. (+192)
23 [GO] 2024―May―22 Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection Debbie E. Malden, In-Lu Amy Liu, Lei Qian, Lina S. Sy, Bruno J. Lewin, Dawn T. Asamura, et al. (+13)
24 [GO] 2024―May―20 Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality Yvan Devaux, Lu Zhang, Andrew I. Lumley, Kanita Karaduzovic-Hadziabdic, Vincent Mooser, Simon Rousseau, et al. (+29)
25 [GO] 2024―May―20 Fatal COVID-19 pulmonary disease involves ferroptosis Baiyu Qiu, Fereshteh Zandkarimi, Anjali Saqi, Candace Castagna, Hui Tan, Miroslav Sekulic, et al. (+5)
26 [GO] 2024―May―18 Spatial disparities in the mortality burden of the covid-19 pandemic across 569 European regions (2020-2021) Florian Bonnet, Pavel Grigoriev, Markus Sauerberg, Ina Alliger, Michael Mühlichen, Carlo-Giovanni Camarda
27 [GO] 2024―May―18 Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, Daryl Geers, Roos S. G. Sablerolles, Susanne Bogers, et al. (+54)
28 [GO] 2024―May―16 Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity Shengjun Wang, Wei Ran, Lingyu Sun, Qingchi Fan, Yuanqi Zhao, Bowen Wang, et al. (+15)
29 [GO] 2024―May―16 Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity Elsa Brunet-Ratnasingham, Sacha Morin, Haley E. Randolph, Marjorie Labrecque, Justin Bélair, Raphaël Lima-Barbosa, et al. (+41)
30 [GO] 2024―May―16 Impacts of human mobility on the citywide transmission dynamics of 18 respiratory viruses in pre- and post-COVID-19 pandemic years Amanda C. Perofsky, Chelsea L. Hansen, Roy Burstein, Shanda Boyle, Robin Prentice, Cooper Marshall, et al. (+24)
31 [GO] 2024―May―14 Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials Nhân Thị Hồ, Steven G. Hughes, Van Thanh Ta, Lân Trọng Phan, Quyết Đỗ, Thượng Vũ Nguyễn, et al. (+31)
32 [GO] 2024―May―14 Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning Ruipeng Lei, Enya Qing, Abby Odle, Meng Yuan, Chaminda D. Gunawardene, Timothy J. C. Tan, et al. (+7)
33 [GO] 2024―May―13 Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes Junqing Xie, Beatriz Mothe, Marta Alcalde Herraiz, Chunxiao Li, Yu Xu, Annika M. Jödicke, et al. (+13)
34 [GO] 2024―May―13 Multiscale modelling of chromatin 4D organization in SARS-CoV-2 infected cells Andrea M. Chiariello, Alex Abraham, Simona Bianco, Andrea Esposito, Andrea Fontana, Francesca Vercellone, et al. (+2)
35 [GO] 2024―May―08 Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic Kangguo Li, Jia Rui, Wentao Song, Li Luo, Yunkang Zhao, Huimin Qu, et al. (+8)
36 [GO] 2024―May―07 High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia Sheikh Jarju, Rhys D. Wenlock, Madikoi Danso, Dawda Jobe, Ya Jankey Jagne, Alansana Darboe, et al. (+20)
37 [GO] 2024―May―07 SARS-CoV-2 Mpro responds to oxidation by forming disulfide and NOS/SONOS bonds Patrick Y. A. Reinke, Robin Schubert, Dominik Oberthür, Marina Galchenkova, Aida Rahmani Mashhour, Sebastian Günther, et al. (+49)
38 [GO] 2024―May―03 Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus Jacob A. Dillard, Sharon A. Taft-Benz, Audrey C. Knight, Elizabeth J. Anderson, Katia D. Pressey, Breantié Parotti, et al. (+25)
39 [GO] 2024―Apr―29 Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19 Hidetoshi Igari, Seiichiro Sakao, Takayuki Ishige, Kengo Saito, Shota Murata, Misuzu Yahaba, et al. (+6)
40 [GO] 2024―Apr―27 The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies Arman Izadi, Yasaman Karami, Eleni Bratanis, Sebastian Wrighton, Hamed Khakzad, Maria Nyblom, et al. (+15)
41 [GO] 2024―Apr―26 Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques Jaclyn A. Kaiser, Christine E. Nelson, Xueqiao Liu, Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, et al. (+21)
42 [GO] 2024―Apr―25 Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk Allen Haddrell, Henry Oswin, Mara Otero-Fernandez, Joshua F. Robinson, Tristan Cogan, Robert Alexander, et al. (+5)
43 [GO] 2024―Apr―24 Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity Simon Merkt, Solomon Ali, Esayas Kebede Gudina, Wondimagegn Adissu, Addisu Gize, Maximilian Muenchhoff, et al. (+18)
44 [GO] 2024―Apr―22 Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease Ruth E. Drury, Susana Camara, Irina Chelysheva, Sagida Bibi, Katherine Sanders, Salle Felle, et al. (+9)
45 [GO] 2024―Apr―21 Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic Estefany Rios-Guzman, Lacy M. Simons, Taylor J. Dean, Francesca Agnes, Anna Pawlowski, Arghavan Alisoltanidehkordi, et al. (+5)
46 [GO] 2024―Apr―20 An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation Seoryeong Park, Jaewon Choi, Yonghee Lee, Jinsung Noh, Namphil Kim, JinAh Lee, et al. (+11)
47 [GO] 2024―Apr―17 Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection Chansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, Katherine J. L. Jackson, Daniel B. Wilson, Bikash Manandhar, et al. (+16)
48 [GO] 2024―Apr―16 Population genetic considerations regarding the interpretation of within-patient SARS-CoV-2 polymorphism data Vivak Soni, John W. Terbot, Jeffrey D. Jensen
49 [GO] 2024―Apr―16 Reply to: Population genetic considerations regarding the interpretation of within-patient SARS-CoV-2 polymorphism data Chase W. Nelson, Leo L. M. Poon, Haogao Gu
50 [GO] 2024―Apr―15 Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study Hilde Marie Engjom, Rema Ramakrishnan, Nicola Vousden, Kathryn Bunch, Edward Morris, Nigel Simpson, et al. (+6)
51 [GO] 2024―Apr―13 Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution Cassia Wagner, Kathryn E. Kistler, Garrett A. Perchetti, Noah Baker, Lauren A. Frisbie, Laura Marcela Torres, et al. (+8)
52 [GO] 2024―Apr―13 Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children Janice Z. Jia, Carolyn A. Cohen, Haogao Gu, Milla R. McLean, Raghavan Varadarajan, Nisha Bhandari, et al. (+8)
53 [GO] 2024―Apr―09 SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals Rebecca Urschel, Saskia Bronder, Verena Klemis, Stefanie Marx, Franziska Hielscher, Amina Abu-Omar, et al. (+10)
54 [GO] 2024―Apr―04 Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses Benedict D. Michael, Cordelia Dunai, Edward J. Needham, Kukatharmini Tharmaratnam, Robyn Williams, Yun Huang, et al. (+559)
55 [GO] 2024―Apr―04 Bat species assemblage predicts coronavirus prevalence Magdalena Meyer, Dominik W. Melville, Heather J. Baldwin, Kerstin Wilhelm, Evans Ewald Nkrumah, Ebenezer K. Badu, et al. (+8)
56 [GO] 2024―Apr―02 Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel Joshua Guedalia, Michal Lipschuetz, Adva Cahen-Peretz, Sarah M. Cohen, Yishai Sompolinsky, Galit Shefer, et al. (+6)
57 [GO] 2024―Mar―29 Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients Sara De Biasi, Domenico Lo Tartaro, Anita Neroni, Moritz Rau, Nikolaos Paschalidis, Rebecca Borella, et al. (+12)
58 [GO] 2024―Mar―28 The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86 Daming Zhou, Piyada Supasa, Chang Liu, Aiste Dijokaite-Guraliuc, Helen M. E. Duyvesteyn, Muneeswaran Selvaraj, et al. (+11)
59 [GO] 2024―Mar―26 Ecological countermeasures to prevent pathogen spillover and subsequent pandemics Raina K. Plowright, Aliyu N. Ahmed, Tim Coulson, Thomas W. Crowther, Imran Ejotre, Christina L. Faust, et al. (+19)
60 [GO] 2024―Mar―21 Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo, Erola Ainsua-Enrich, Marco Brustolin, María Luisa Rodríguez de la Concepción, et al. (+27)
61 [GO] 2024―Mar―18 Projecting the long-term effects of the COVID-19 pandemic on U.S. population structure Andrea M. Tilstra, Antonino Polizzi, Sander Wagner, Evelina T. Akimova
62 [GO] 2024―Mar―15 Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts Sarah J. Aldridge, Utkarsh Agrawal, Siobhán Murphy, Tristan Millington, Ashley Akbari, Fatima Almaghrabi, et al. (+14)
63 [GO] 2024―Mar―15 Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation Farina Karim, Catherine Riou, Mallory Bernstein, Zesuliwe Jule, Gila Lustig, Strauss van Graan, et al. (+25)
64 [GO] 2024―Mar―14 Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models Franziska K. Kaiser, Mariana Gonzalez Hernandez, Nadine Krüger, Ellinor Englund, Wenjuan Du, Anna Z. Mykytyn, et al. (+27)
65 [GO] 2024―Mar―13 Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion Delphine Planas, Isabelle Staropoli, Vincent Michel, Frederic Lemoine, Flora Donati, Matthieu Prot, et al. (+19)
66 [GO] 2024―Mar―12 Author Correction: Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context Richard J. Sheppard, Oliver J. Watson, Rachel Pieciak, James Lungu, Geoffrey Kwenda, Crispin Moyo, et al. (+17)
67 [GO] 2024―Mar―11 Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study Genevieve I. Cezard, Rachel E. Denholm, Rochelle Knight, Yinghui Wei, Lucy Teece, Renin Toms, et al. (+26)
68 [GO] 2024―Mar―09 Drivers and impact of the early silent invasion of SARS-CoV-2 Alpha Benjamin Faucher, Chiara E. Sabbatini, Peter Czuppon, Moritz U. G. Kraemer, Philippe Lemey, Vittoria Colizza, et al. (+3)
69 [GO] 2024―Mar―07 Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2 Dongtak Lee, Hyo Gi Jung, Dongsung Park, Junho Bang, Da Yeon Cheong, Jae Won Jang, et al. (+9)
70 [GO] 2024―Mar―07 NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins Ilya Tsukalov, Ildefonso Sánchez-Cerrillo, Olga Rajas, Elena Avalos, Gorane Iturricastillo, Laura Esparcia, et al. (+18)
71 [GO] 2024―Mar―06 SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle Kshitiz Walia, Abhishek Sharma, Sankalita Paul, Priya Chouhan, Gaurav Kumar, Rajesh Ringe, et al. (+2)
72 [GO] 2024―Mar―06 Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States Hailey J. Park, Gregg S. Gonsalves, Sophia T. Tan, J. Daniel Kelly, George W. Rutherford, Robert M. Wachter, et al. (+3)
73 [GO] 2024―Mar―05 Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants S. Jaumdally, M. Tomasicchio, A. Pooran, A. Esmail, A. Kotze, S. Meier, et al. (+20)
74 [GO] 2024―Feb―29 Inequalities in healthcare use during the COVID-19 pandemic Arun Frey, Andrea M. Tilstra, Mark D. Verhagen
75 [GO] 2024―Feb―29 Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein Dhiraj Mannar, James W. Saville, Chad Poloni, Xing Zhu, Alison Bezeruk, Keith Tidey, et al. (+7)
76 [GO] 2024―Feb―28 Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean Tiago Gräf, Alexander A. Martinez, Gonzalo Bello, Simon Dellicour, Philippe Lemey, Vittoria Colizza, et al. (+81)
77 [GO] 2024―Feb―26 Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection Ivan Chun Hang Lam, Ran Zhang, Kenneth Keng Cheung Man, Carlos King Ho Wong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, et al. (+5)
78 [GO] 2024―Feb―23 Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients Joseph F. Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A. Agyeman, et al. (+47)
79 [GO] 2024―Feb―20 Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge Ching-Lin Hsieh, Sarah R. Leist, Emily Happy Miller, Ling Zhou, John M. Powers, Alexandra L. Tse, et al. (+8)
80 [GO] 2024―Feb―19 Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study John S. Kim, Yifei Sun, Pallavi Balte, Mary Cushman, Rebekah Boyle, Russell P. Tracy, et al. (+27)
81 [GO] 2024―Feb―17 COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase Matthew J. Cummings, Barnabas Bakamutumaho, Julius J. Lutwama, Nicholas Owor, Xiaoyu Che, Maider Astorkia, et al. (+21)
82 [GO] 2024―Feb―16 Changes in social norms during the early stages of the COVID-19 pandemic across 43 countries Giulia Andrighetto, Aron Szekely, Andrea Guido, Michele Gelfand, Jered Abernathy, Gizem Arikan, et al. (+76)
83 [GO] 2024―Feb―09 Comparative effectiveness of alternative intervals between first and second doses of the mRNA COVID-19 vaccines Kayoko Shioda, Alexander Breskin, Pravara Harati, Allison T. Chamberlain, Toshiaki Komura, Benjamin A. Lopman, Elizabeth T. Rogawski McQuade
84 [GO] 2024―Feb―08 Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, Hisano Yajima, Masumi Tsuda, Hesham Nasser, et al. (+83)
85 [GO] 2024―Feb―05 Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, Janneke van’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo, et al. (+88)
86 [GO] 2024―Feb―05 Isolation and characterization of a pangolin-borne HKU4-related coronavirus that potentially infects human-DPP4-transgenic mice Luo-Yuan Xia, Zhen-Fei Wang, Xiao-Ming Cui, Yuan-Guo Li, Run-Ze Ye, Dai-Yun Zhu, et al. (+12)
87 [GO] 2024―Feb―05 A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity Leire de Campos-Mata, Benjamin Trinité, Andrea Modrego, Sonia Tejedor Vaquero, Edwards Pradenas, Anna Pons-Grífols, et al. (+19)
88 [GO] 2024―Feb―02 Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population Jia Wei, Nicole Stoesser, Philippa C. Matthews, Tarnjit Khera, Owen Gethings, Ian Diamond, et al. (+67)
89 [GO] 2024―Feb―02 An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission Julia M. Adler, Ricardo Martin Vidal, Christine Langner, Daria Vladimirova, Azza Abdelgawad, Daniela Kunecova, et al. (+9)
90 [GO] 2024―Feb―02 A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection Lorena M. Coria, Juan Manuel Rodriguez, Agostina Demaria, Laura A. Bruno, Mayra Rios Medrano, Celeste Pueblas Castro, et al. (+28)
91 [GO] 2024―Jan―31 Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Peter Sandercock, Janet Darbyshire, David DeMets, Robert Fowler, David Lalloo, Mohammed Munavvar, et al. (+2047)
92 [GO] 2024―Jan―30 Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination Nadège Nziza, Yixiang Deng, Lianna Wood, Navneet Dhanoa, Naomi Dulit-Greenberg, Tina Chen, et al. (+16)
93 [GO] 2024―Jan―30 Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue Guoli Shi, Tiansheng Li, Kin Kui Lai, Reed F. Johnson, Jonathan W. Yewdell, Alex A. Compton
94 [GO] 2024―Jan―29 Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants Yanqun Wang, An Yan, Deyong Song, Maoqin Duan, Chuangchuang Dong, Jiantao Chen, et al. (+29)
95 [GO] 2024―Jan―26 Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, Kristen Valentine, Paolla Beatriz Almeida Pinto, Andrew Gonzalez, et al. (+16)
96 [GO] 2024―Jan―25 Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients Erik Duijvelaar, Jack Gisby, James E. Peters, Harm Jan Bogaard, Jurjan Aman
97 [GO] 2024―Jan―24 Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study Olivia M. Man, Tamiris Azamor, Mary Catherine Cambou, Trevon L. Fuller, Tara Kerin, Sophia G. Paiola, et al. (+8)
98 [GO] 2024―Jan―20 Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly Emilie Murigneux, Laurent Softic, Corentin Aubé, Carmen Grandi, Delphine Judith, Johanna Bruce, et al. (+8)
99 [GO] 2024―Jan―18 Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity Quy Xiao Xuan Lin, Deepa Rajagopalan, Akshamal M. Gamage, Le Min Tan, Prasanna Nori Venkatesh, Wharton O. Y. Chan, et al. (+18)
100 [GO] 2024―Jan―18 Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models Lays Cordeiro Guimaraes, Pedro Augusto Carvalho Costa, Sérgio Ricardo Aluotto Scalzo Júnior, Heloísa Athaydes Seabra Ferreira, Ana Carolina Soares Braga, Leonardo Camilo de Oliveira, et al. (+19)
101 [GO] 2024―Jan―16 Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England Isobel L. Ward, Chris Robertson, Utkarsh Agrawal, Lynsey Patterson, Declan T. Bradley, Ting Shi, et al. (+4)
102 [GO] 2024―Jan―15 Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples Orsolya Anna Pipek, Anna Medgyes-Horváth, József Stéger, Krisztián Papp, Dávid Visontai, Marion Koopmans, et al. (+14)
103 [GO] 2024―Jan―09 IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition Benjamin S. Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, Jennifer Connors, Gina Cusimano, Mathew Bell, et al. (+362)
104 [GO] 2024―Jan―09 Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design Lisa-Marie Funk, Gereon Poschmann, Fabian Rabe von Pappenheim, Ashwin Chari, Kim M. Stegmann, Antje Dickmanns, et al. (+15)
105 [GO] 2024―Jan―08 Estimating the heritability of SARS-CoV-2 susceptibility and COVID-19 severity Kathleen LaRow Brown, Vijendra Ramlall, Michael Zietz, Undina Gisladottir, Nicholas P. Tatonetti
106 [GO] 2024―Jan―08 Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men Suad Hannawi, Linda Saf Eldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, Aala Hassan, et al. (+9)
107 [GO] 2024―Jan―04 Dynamic predictors of COVID-19 vaccination uptake and their interconnections over two years in Hong Kong Jiehu Yuan, Yucan Xu, Irene Oi Ling Wong, Wendy Wing Tak Lam, Michael Y. Ni, Benjamin J. Cowling, Qiuyan Liao
108 [GO] 2024―Jan―04 TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence Jiang Ren, Shuai Wang, Zhi Zong, Ting Pan, Sijia Liu, Wei Mao, et al. (+6)
109 [GO] 2024―Jan―04 A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potential Gregory H. Bird, J. J. Patten, William Zavadoski, Nicole Barucci, Marina Godes, Benjamin M. Moyer, et al. (+6)
110 [GO] 2024―Jan―04 Muscle abnormalities worsen after post-exertional malaise in long COVID Brent Appelman, Braeden T. Charlton, Richie P. Goulding, Tom J. Kerkhoff, Ellen A. Breedveld, Wendy Noort, et al. (+10)
111 [GO] 2024―Jan―03 Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study Al Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, Esther Melamed, Carly E. Milliren, Jingjing Qi, et al. (+350)
112 [GO] 2024―Jan―02 Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection Jiakai Hou, Yanjun Wei, Jing Zou, Roshni Jaffery, Long Sun, Shaoheng Liang, et al. (+15)
113 [GO] 2023―Dec―22 Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses Benedict D. Michael, Cordelia Dunai, Edward J. Needham, Kukatharmini Tharmaratnam, Robyn Williams, Yun Huang, et al. (+556)
114 [GO] 2023―Dec―20 Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19 Rae Maeda, Natsumi Seki, Yoshifumi Uwamino, Masatoshi Wakui, Yu Nakagama, Yasutoshi Kido, et al. (+13)
115 [GO] 2023―Dec―20 Quantitatively assessing early detection strategies for mitigating COVID-19 and future pandemics Andrew Bo Liu, Daniel Lee, Amogh Prabhav Jalihal, William P. Hanage, Michael Springer
116 [GO] 2023―Dec―16 Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation Carlos K. H. Wong, Jonathan J. Lau, Ivan C. H. Au, Kristy T. K. Lau, Ivan F. N. Hung, Malik Peiris, et al. (+2)
117 [GO] 2023―Dec―15 A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs Debajit Dey, Enya Qing, Yanan He, Yihong Chen, Benjamin Jennings, Whitaker Cohn, et al. (+9)
118 [GO] 2023―Dec―12 Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2 Kerry L. Hilligan, Sivaranjani Namasivayam, Chad S. Clancy, Paul J. Baker, Samuel I. Old, Victoria Peluf, et al. (+13)
119 [GO] 2023―Dec―09 The DNA glycosylase NEIL2 is protective during SARS-CoV-2 infection Nisha Tapryal, Anirban Chakraborty, Kaushik Saha, Azharul Islam, Lang Pan, Koa Hosoki, et al. (+17)
120 [GO] 2023―Dec―07 Author Correction: Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England Pablo N. Perez-Guzman, Edward Knock, Natsuko Imai, Thomas Rawson, Yasin Elmaci, Joana Alcada, et al. (+11)
121 [GO] 2023―Dec―06 Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant Khadija Khan, Gila Lustig, Cornelius Römer, Kajal Reedoy, Zesuliwe Jule, Farina Karim, et al. (+23)
122 [GO] 2023―Dec―05 A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection Wanbo Tai, Kai Yang, Yubin Liu, Ruofan Li, Shengyong Feng, Benjie Chai, et al. (+15)
123 [GO] 2023―Dec―04 Author Correction: Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants Guilherme Dias de Melo, Victoire Perraud, Flavio Alvarez, Alba Vieites-Prado, Seonhee Kim, Lauriane Kergoat, et al. (+16)
124 [GO] 2023―Dec―02 Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs Alvin X. Han, Emma Hannay, Sergio Carmona, Bill Rodriguez, Brooke E. Nichols, Colin A. Russell
125 [GO] 2023―Dec―02 Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates Chaim A. Schramm, Damee Moon, Lowrey Peyton, Noemia S. Lima, Christian Wake, Kristin L. Boswell, et al. (+12)
126 [GO] 2023―Dec―01 Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children Lorenza Bellusci, Gabrielle Grubbs, Shaimaa Sait, Lael M. Yonker, Adrienne G. Randolph, Tanya Novak, et al. (+2)
127 [GO] 2023―Nov―30 Engineered immunogens to elicit antibodies against conserved coronavirus epitopes A. Brenda Kapingidza, Daniel J. Marston, Caitlin Harris, Daniel Wrapp, Kaitlyn Winters, Dieter Mielke, et al. (+33)
128 [GO] 2023―Nov―30 SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle Liv Zimmermann, Xiaohan Zhao, Jana Makroczyova, Moritz Wachsmuth-Melm, Vibhu Prasad, Zach Hensel, et al. (+2)
129 [GO] 2023―Nov―30 Utilizing river and wastewater as a SARS-CoV-2 surveillance tool in settings with limited formal sewage systems Kayla G. Barnes, Joshua I. Levy, Jillian Gauld, Jonathan Rigby, Oscar Kanjerwa, Christopher B. Uzzell, et al. (+20)
130 [GO] 2023―Nov―27 Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study Alessia Raineri, Thomas Radtke, Sonja Rueegg, Sarah R. Haile, Dominik Menges, Tala Ballouz, et al. (+8)
131 [GO] 2023―Nov―21 Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution Junya Sunagawa, Hyeongki Park, Kwang Su Kim, Ryo Komorizono, Sooyoun Choi, Lucia Ramirez Torres, et al. (+7)
132 [GO] 2023―Nov―21 Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry Haofeng Wang, Qi Yang, Xiaoce Liu, Zili Xu, Maolin Shao, Dongxu Li, et al. (+16)
133 [GO] 2023―Nov―20 Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertainty Emily Howerton, Lucie Contamin, Luke C. Mullany, Michelle Qin, Nicholas G. Reich, Samantha Bents, et al. (+77)
134 [GO] 2023―Nov―17 “The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis” Kristin Kostka, Elena Roel, Nhung T. H. Trinh, Núria Mercadé-Besora, Antonella Delmestri, Lourdes Mateu, et al. (+5)
135 [GO] 2023―Nov―15 Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity Maaike C. Swets, Steven Kerr, James Scott-Brown, Adam B. Brown, Rishi Gupta, Jonathan E. Millar, et al. (+17)
136 [GO] 2023―Nov―13 Impact of vaccinations, boosters and lockdowns on COVID-19 waves in French Polynesia Lloyd A. C. Chapman, Maite Aubry, Noémie Maset, Timothy W. Russell, Edward S. Knock, John A. Lees, et al. (+3)
137 [GO] 2023―Nov―11 SARS-CoV-2 hijacks a cell damage response, which induces transcription of a more efficient Spike S-acyltransferase Francisco S. Mesquita, Laurence Abrami, Lucie Bracq, Nattawadee Panyain, Vincent Mercier, Béatrice Kunz, et al. (+4)
138 [GO] 2023―Nov―08 Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs Praveen Weeratunga, Laura Denney, Joshua A. Bull, Emmanouela Repapi, Martin Sergeant, Rachel Etherington, et al. (+25)
139 [GO] 2023―Nov―07 Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans David Chmielewski, Eric A. Wilson, Grigore Pintilie, Peng Zhao, Muyuan Chen, Michael F. Schmid, et al. (+5)
140 [GO] 2023―Nov―06 An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission Weizhong Li, Tao Wang, Arunraj M. Rajendrakumar, Gyanada Acharya, Zizhen Miao, Berin P. Varghese, et al. (+6)
141 [GO] 2023―Nov―03 Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology Daniel N. Streblow, Alec J. Hirsch, Jeffrey J. Stanton, Anne D. Lewis, Lois Colgin, Ann J. Hessell, et al. (+28)
142 [GO] 2023―Nov―02 Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time Grace Kenny, Sophie O’Reilly, Neil Wrigley Kelly, Riya Negi, Colette Gaillard, Dana Alalwan, et al. (+27)
143 [GO] 2023―Nov―01 Defining neutralization and allostery by antibodies against COVID-19 variants Nikhil Kumar Tulsian, Raghuvamsi Venkata Palur, Xinlei Qian, Yue Gu, Bhuvaneshwari D/O Shunmuganathan, Firdaus Samsudin, et al. (+10)
144 [GO] 2023―Oct―28 Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study M. Otiende, A. Nyaguara, C. Bottomley, D. Walumbe, G. Mochamah, D. Amadi, et al. (+20)
145 [GO] 2023―Oct―28 Antiviral responses in a Jamaican fruit bat intestinal organoid model of SARS-CoV-2 infection Marziah Hashimi, T. Andrew Sebrell, Jodi F. Hedges, Deann Snyder, Katrina N. Lyon, Stephanie D. Byrum, et al. (+15)
146 [GO] 2023―Oct―27 Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile Alejandro Jara, Cristobal Cuadrado, Eduardo A. Undurraga, Christian García, Manuel Nájera, María Paz Bertoglia, et al. (+4)
147 [GO] 2023―Oct―27 Using drivers and transmission pathways to identify SARS-like coronavirus spillover risk hotspots Renata L. Muylaert, David A. Wilkinson, Tigga Kingston, Paolo D’Odorico, Maria Cristina Rulli, Nikolas Galli, et al. (+3)
148 [GO] 2023―Oct―26 Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination Elena Mitsi, Mariana O. Diniz, Jesús Reiné, Andrea M. Collins, Ryan E. Robinson, Angela Hyder-Wright, et al. (+14)
149 [GO] 2023―Oct―24 Long-term health impacts of COVID-19 among 242,712 adults in England Christina J. Atchison, Bethan Davies, Emily Cooper, Adam Lound, Matthew Whitaker, Adam Hampshire, et al. (+6)
150 [GO] 2023―Oct―23 Individual level analysis of digital proximity tracing for COVID-19 in Belgium highlights major bottlenecks Caspar Geenen, Joren Raymenants, Sarah Gorissen, Jonathan Thibaut, Jodie McVernon, Natalie Lorent, Emmanuel André
151 [GO] 2023―Oct―23 Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination Malika Aid, Kathryn E. Stephenson, Ai-ris Y. Collier, Joseph P. Nkolola, James V. Michael, Steven E. McKenzie, Dan H. Barouch
152 [GO] 2023―Oct―23 SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors Cecily Choy, Joseph Chen, Jiangyuan Li, D. Travis Gallagher, Jian Lu, Daichao Wu, et al. (+32)
153 [GO] 2023―Oct―18 Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters Julia R. Port, Claude Kwe Yinda, Jade C. Riopelle, Zachary A. Weishampel, Taylor A. Saturday, Victoria A. Avanzato, et al. (+11)
154 [GO] 2023―Oct―13 Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir Xiangrui Jiang, Haixia Su, Weijuan Shang, Feng Zhou, Yan Zhang, Wenfeng Zhao, et al. (+16)
155 [GO] 2023―Oct―11 SARS-CoV-2 infection of human lung epithelial cells induces TMPRSS-mediated acute fibrin deposition Rachel Erickson, Chang Huang, Cameron Allen, Joanna Ireland, Gwynne Roth, Zhongcheng Zou, et al. (+12)
156 [GO] 2023―Oct―10 SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses Mukhlid Yousif, Said Rachida, Setshaba Taukobong, Nkosenhle Ndlovu, Chinwe Iwu-Jaja, Wayne Howard, et al. (+13)
157 [GO] 2023―Oct―10 Development and validation of the pandemic fatigue scale Lau Lilleholt, Ingo Zettler, Cornelia Betsch, Robert Böhm
158 [GO] 2023―Oct―07 A hybrid register and questionnaire study of Covid-19 and post-acute sick leave in Denmark Elisabeth O’Regan, Ingrid Bech Svalgaard, Anna Irene Vedel Sørensen, Lampros Spiliopoulos, Peter Bager, Nete Munk Nielsen, et al. (+4)
159 [GO] 2023―Oct―06 Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq Sara Sunshine, Andreas S. Puschnik, Joseph M. Replogle, Matthew T. Laurie, Jamin Liu, Beth Shoshana Zha, et al. (+12)
160 [GO] 2023―Oct―05 Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates Payton A.-B. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S. Arunachalam, Mengyun Hu, et al. (+14)
161 [GO] 2023―Oct―05 Viral kinetics of sequential SARS-CoV-2 infections Stephen M. Kissler, James A. Hay, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Deverick J. Anderson, et al. (+3)
162 [GO] 2023―Oct―04 Alternative splicing in lung influences COVID-19 severity and respiratory diseases Tomoko Nakanishi, Julian Willett, Yossi Farjoun, Richard J. Allen, Beatriz Guillen-Guio, Darin Adra, et al. (+2)
163 [GO] 2023―Oct―04 Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera Geoffrey B. Hutchinson, Olubukola M. Abiona, Cynthia T. Ziwawo, Anne P. Werner, Daniel Ellis, Yaroslav Tsybovsky, et al. (+15)
164 [GO] 2023―Sep―26 Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2 Magen E. Francis, Ethan B. Jansen, Anthony Yourkowski, Alaa Selim, Cynthia L. Swan, Brian K. MacPhee, et al. (+11)
165 [GO] 2023―Sep―22 Comprehensive proteomics and meta-analysis of COVID-19 host response Haris Babačić, Wanda Christ, José Eduardo Araújo, Georgios Mermelekas, Nidhi Sharma, Janne Tynell, et al. (+8)
166 [GO] 2023―Sep―20 mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, Julia E. Tubert, Yi Luo, Sijia Qiu, et al. (+12)
167 [GO] 2023―Sep―20 Predictors of the post-COVID condition following mild SARS-CoV-2 infection B-A. Reme, J. Gjesvik, K. Magnusson
168 [GO] 2023―Sep―18 Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection Tomalika R. Ullah, Matt D. Johansen, Katherine R. Balka, Rebecca L. Ambrose, Linden J. Gearing, James Roest, et al. (+27)
169 [GO] 2023―Sep―18 Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation Qi Zhang, Weichun Tang, Eduardo Stancanelli, Eunkyung Jung, Zulfeqhar Syed, Vijayakanth Pagadala, et al. (+12)
170 [GO] 2023―Sep―13 Author Correction: National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age Laura A. Magee, Erika Molteni, Vicky Bowyer, Jeffrey N. Bone, Harriet Boulding, Asma Khalil, et al. (+17)
171 [GO] 2023―Sep―13 Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets Filip Mihalič, Caroline Benz, Eszter Kassa, Richard Lindqvist, Leandro Simonetti, Raviteja Inturi, et al. (+7)
172 [GO] 2023―Sep―12 Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk Laura Pérez-Alós, Cecilie Bo Hansen, Jose Juan Almagro Armenteros, Johannes Roth Madsen, Line Dam Heftdal, Rasmus Bo Hasselbalch, et al. (+13)
173 [GO] 2023―Sep―12 The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease Norman Tran, Sathish Dasari, Sarah A. E. Barwell, Matthew J. McLeod, Subha Kalyaanamoorthy, Todd Holyoak, Aravindhan Ganesan
174 [GO] 2023―Sep―08 Panoramic analysis of coronaviruses carried by representative bat species in Southern China to better understand the coronavirus sphere Yelin Han, Panpan Xu, Yuyang Wang, Wenliang Zhao, Junpeng Zhang, Shuyi Zhang, et al. (+3)
175 [GO] 2023―Sep―06 Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection Denis Mongin, Nils Bürgisser, Gustavo Laurie, Guillaume Schimmel, Diem-Lan Vu, Stephane Cullati, et al. (+38)
176 [GO] 2023―Aug―29 Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study Laura Lindsay, Clara Calvert, Ting Shi, Jade Carruthers, Cheryl Denny, Jack Donaghy, et al. (+15)
177 [GO] 2023―Aug―29 Effects of public-health measures for zeroing out different SARS-CoV-2 variants Yong Ge, Xilin Wu, Wenbin Zhang, Xiaoli Wang, Die Zhang, Jianghao Wang, et al. (+11)
178 [GO] 2023―Aug―28 Accelerated evolution of SARS-CoV-2 in free-ranging white-tailed deer Dillon S. McBride, Sofya K. Garushyants, John Franks, Andrew F. Magee, Steven H. Overend, Devra Huey, et al. (+23)
179 [GO] 2023―Aug―26 Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography Annika Rössler, Antonia Netzl, Ludwig Knabl, David Bante, Samuel H. Wilks, Wegene Borena, et al. (+3)
180 [GO] 2023―Aug―25 An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants Juan Liu, Fengfeng Mao, Jianhe Chen, Shuaiyao Lu, Yonghe Qi, Yinyan Sun, et al. (+33)
181 [GO] 2023―Aug―24 SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations Andrew P. Hederman, Harini Natarajan, Leo Heyndrickx, Kevin K. Ariën, Joshua A. Wiener, Peter F. Wright, et al. (+10)
182 [GO] 2023―Aug―23 Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity Daniel M. Altmann, Catherine J. Reynolds, George Joy, Ashley D. Otter, Joseph M. Gibbons, Corinna Pade, et al. (+10)
183 [GO] 2023―Aug―23 Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R. Walsh, Brandon Essink, Adam Brosz, et al. (+11)
184 [GO] 2023―Aug―21 CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis Zihan Tang, Yanyan Xu, Yun Tan, Hui Shi, Peipei Jin, Yunqi Li, et al. (+19)
185 [GO] 2023―Aug―19 Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population Margaret L. Lind, Murilo Dorion, Amy J. Houde, Mary Lansing, Sarah Lapidus, Russell Thomas, et al. (+9)
186 [GO] 2023―Aug―18 Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne M. Rittig, et al. (+31)
187 [GO] 2023―Aug―18 Attaching protein-adsorbing silica particles to the surface of cotton substrates for bioaerosol capture including SARS-CoV-2 Kieran Collings, Cedric Boisdon, Tung-Ting Sham, Kevin Skinley, Hyun-Kyung Oh, Tessa Prince, et al. (+9)
188 [GO] 2023―Aug―16 SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people Matthew Whitaker, Bethan Davies, Christina Atchison, Wendy Barclay, Deborah Ashby, Ara Darzi, et al. (+6)
189 [GO] 2023―Aug―15 Inequalities in COVID-19 severe morbidity and mortality by country of birth in Sweden Mikael Rostila, Agneta Cederström, Matthew Wallace, Siddartha Aradhya, Malin Ahrne, Sol P. Juárez
190 [GO] 2023―Aug―11 Elevated binding and functional antibody responses to SARS-CoV-2 in infants versus mothers Caitlin I. Stoddard, Kevin Sung, Zak A. Yaffe, Haidyn Weight, Guillaume Beaudoin-Bussières, Jared Galloway, et al. (+11)
191 [GO] 2023―Aug―10 Genomic epidemiology offers high resolution estimates of serial intervals for COVID-19 Jessica E. Stockdale, Kurnia Susvitasari, Paul Tupper, Benjamin Sobkowiak, Nicola Mulberry, Anders Gonçalves da Silva, et al. (+6)
192 [GO] 2023―Aug―10 SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates Elisabeth A. Murphy, Camila Guzman-Cardozo, Ashley C. Sukhu, Debby J. Parks, Malavika Prabhu, Iman Mohammed, et al. (+12)
193 [GO] 2023―Aug―09 Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology Brechje de Gier, Anne J. Huiberts, Christina E. Hoeve, Gerco den Hartog, Henri van Werkhoven, Rob van Binnendijk, et al. (+4)
194 [GO] 2023―Aug―08 Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults Hangjie Zhang, Nani Xu, Yu Xu, Pan Qin, Rongrong Dai, Bicheng Xu, et al. (+10)
195 [GO] 2023―Aug―07 Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models Robert M. Cox, Carolin M. Lieber, Josef D. Wolf, Amirhossein Karimi, Nicole A. P. Lieberman, Zachary M. Sticher, et al. (+8)
196 [GO] 2023―Aug―03 Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection Junqing Xie, Yuliang Feng, Danielle Newby, Bang Zheng, Qi Feng, Albert Prats-Uribe, et al. (+4)
197 [GO] 2023―Jul―29 Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2 Tomer Hertz, Shlomia Levy, Daniel Ostrovsky, Hanna Oppenheimer, Shosh Zismanov, Alona Kuzmina, et al. (+21)
198 [GO] 2023―Jul―28 Monoclonal antibody levels and protection from COVID-19 Eva Stadler, Martin T. Burgess, Timothy E. Schlub, Shanchita R. Khan, Khai Li Chai, Zoe K. McQuilten, et al. (+6)
199 [GO] 2023―Jul―28 Wastewater-based epidemiology predicts COVID-19-induced weekly new hospital admissions in over 150 USA counties Xuan Li, Huan Liu, Li Gao, Samendra P. Sherchan, Ting Zhou, Stuart J. Khan, et al. (+2)
200 [GO] 2023―Jul―28 Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults Karina A. Pasquevich, Lorena M. Coria, Ana Ceballos, Bianca Mazzitelli, Juan Manuel Rodriguez, Agostina Demaría, et al. (+34)
201 [GO] 2023―Jul―26 Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants Guilherme Dias de Melo, Victoire Perraud, Flavio Alvarez, Alba Vieites-Prado, Seonhee Kim, Lauriane Kergoat, et al. (+16)
202 [GO] 2023―Jul―25 Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19 Shelly J. Robertson, Olivia Bedard, Kristin L. McNally, Carl Shaia, Chad S. Clancy, Matthew Lewis, et al. (+23)
203 [GO] 2023―Jul―19 Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach Alexandra B. Hogan, Patrick Doohan, Sean L. Wu, Daniela Olivera Mesa, Jaspreet Toor, Oliver J. Watson, et al. (+7)
204 [GO] 2023―Jul―17 Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England Pablo N. Perez-Guzman, Edward Knock, Natsuko Imai, Thomas Rawson, Yasin Elmaci, Joana Alcada, et al. (+11)
205 [GO] 2023―Jul―17 Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters Rafael R. G. Machado, Jordyn L. Walker, Dionna Scharton, Grace H. Rafael, Brooke M. Mitchell, Rachel A. Reyna, et al. (+6)
206 [GO] 2023―Jul―15 Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up Clara S. Grønkjær, Rune H. B. Christensen, Daniel Kondziella, Michael E. Benros
207 [GO] 2023―Jul―15 In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir Maki Kiso, Seiya Yamayoshi, Shun Iida, Yuri Furusawa, Yuichiro Hirata, Ryuta Uraki, et al. (+3)
208 [GO] 2023―Jul―14 Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants Saya Moriyama, Yuki Anraku, Shunta Taminishi, Yu Adachi, Daisuke Kuroda, Shunsuke Kita, et al. (+18)
209 [GO] 2023―Jul―14 Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID Matthew C. Woodruff, Kevin S. Bonham, Fabliha A. Anam, Tiffany A. Walker, Caterina E. Faliti, Yusho Ishii, et al. (+19)
210 [GO] 2023―Jul―13 Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination X. Tong, R. P. McNamara, M. J. Avendaño, E. F. Serrano, T. García-Salum, C. Pardo-Roa, et al. (+9)
211 [GO] 2023―Jul―11 Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters Liang Zhang, Yao Jiang, Jinhang He, Junyu Chen, Ruoyao Qi, Lunzhi Yuan, et al. (+36)
212 [GO] 2023―Jul―10 Real-time environmental surveillance of SARS-CoV-2 aerosols Joseph V. Puthussery, Dishit P. Ghumra, Kevin R. McBrearty, Brookelyn M. Doherty, Benjamin J. Sumlin, Amirhossein Sarabandi, et al. (+11)
213 [GO] 2023―Jul―10 Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States Aijing Feng, Sarah Bevins, Jeff Chandler, Thomas J. DeLiberto, Ria Ghai, Kristina Lantz, et al. (+8)
214 [GO] 2023―Jul―10 IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation Srikanth Sadhu, Rajdeep Dalal, Jyotsna Dandotiya, Akshay Binayke, Virendra Singh, Manas Ranjan Tripathy, et al. (+5)
215 [GO] 2023―Jul―08 Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men Suad Hannawi, Linda Saifeldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, Aala Hassan, et al. (+9)
216 [GO] 2023―Jul―06 Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking Sophie Graham, Elise Tessier, Julia Stowe, Jamie Lopez Bernal, Edward P. K. Parker, Dorothea Nitsch, et al. (+4)
217 [GO] 2023―Jul―06 Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target Bo Qin, Ziheng Li, Kaiming Tang, Tongyun Wang, Yubin Xie, Sylvain Aumonier, et al. (+3)
218 [GO] 2023―Jul―04 An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo Moriya Tsuji, Manoj S. Nair, Kazuya Masuda, Candace Castagna, Zhenlu Chong, Tamarand L. Darling, et al. (+12)
219 [GO] 2023―Jul―04 In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir Maki Kiso, Yuri Furusawa, Ryuta Uraki, Masaki Imai, Seiya Yamayoshi, Yoshihiro Kawaoka
220 [GO] 2023―Jun―30 High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection Minami Nagai, Miyu Moriyama, Chiharu Ishii, Hirotake Mori, Hikaru Watanabe, Taku Nakahara, et al. (+9)
221 [GO] 2023―Jun―29 Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context Richard J. Sheppard, Oliver J. Watson, Rachel Pieciak, James Lungu, Geoffrey Kwenda, Crispin Moyo, et al. (+17)
222 [GO] 2023―Jun―29 Immunological imprinting of humoral immunity to SARS-CoV-2 in children Alexander C. Dowell, Tara Lancaster, Rachel Bruton, Georgina Ireland, Christopher Bentley, Panagiota Sylla, et al. (+24)
223 [GO] 2023―Jun―29 Increased vaccine sensitivity of an emerging SARS-CoV-2 variant Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, et al. (+2)
224 [GO] 2023―Jun―27 Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade Juan Carlos Yam-Puc, Zhaleh Hosseini, Emily C. Horner, Pehuén Pereyra Gerber, Nonantzin Beristain-Covarrubias, Robert Hughes, et al. (+40)
225 [GO] 2023―Jun―27 Genomic screening of 16 UK native bat species through conservationist networks uncovers coronaviruses with zoonotic potential Cedric C. S. Tan, Jahcub Trew, Thomas P. Peacock, Kai Yi Mok, Charlie Hart, Kelvin Lau, et al. (+19)
226 [GO] 2023―Jun―27 In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting Wen Juan Tu, Michelle Melino, Jenny Dunn, Robert D. McCuaig, Helle Bielefeldt-Ohmann, Sofiya Tsimbalyuk, et al. (+20)
227 [GO] 2023―Jun―22 Mutagenesis and structural studies reveal the basis for the specific binding of SARS-CoV-2 SL3 RNA element with human TIA1 protein Dong Zhang, Lulu Qiao, Xiaobo Lei, Xiaojing Dong, Yunguang Tong, Jianwei Wang, et al. (+2)
228 [GO] 2023―Jun―17 Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration Dean Follmann, Meagan P. O’Brien, Jonathan Fintzi, Michael P. Fay, David Montefiori, Allyson Mateja, et al. (+18)
229 [GO] 2023―Jun―16 Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2 Katherine U. Gaynor, Marina Vaysburd, Maximilian A. J. Harman, Anna Albecka, Phillip Jeffrey, Paul Beswick, et al. (+26)
230 [GO] 2023―Jun―15 Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city Joseph A. Lewnard, Chandra Mohan B, Gagandeep Kang, Ramanan Laxminarayan
231 [GO] 2023―Jun―15 Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru Santiago Justo Arevalo, Carmen Sofia Uribe Calampa, Cinthy Jimenez Silva, Mauro Quiñones Aguilar, Remco Bouckaert, Joao Renato Rebello Pinho
232 [GO] 2023―Jun―15 Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection Yu Guo, Guangshun Zhang, Qi Yang, Xiaowei Xie, Yang Lu, Xuelian Cheng, et al. (+33)
233 [GO] 2023―Jun―13 Author Correction: Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19 Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, Nino Stocker, Anja Heider, Patrick Westermann, et al. (+19)
234 [GO] 2023―Jun―13 Predicting the antigenic evolution of SARS-COV-2 with deep learning Wenkai Han, Ningning Chen, Xinzhou Xu, Adil Sahil, Juexiao Zhou, Zhongxiao Li, et al. (+7)
235 [GO] 2023―Jun―10 Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response Xiaolei Wang, Terrence Tsz-Tai Yuen, Ying Dou, Jingchu Hu, Renhao Li, Zheng Zeng, et al. (+10)
236 [GO] 2023―Jun―09 Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants Charles B. Stauft, Prabhuanand Selvaraj, Felice D’Agnillo, Clement A. Meseda, Shufeng Liu, Cyntia L. Pedro, et al. (+5)
237 [GO] 2023―Jun―09 A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon Debjit Khan, Fulvia Terenzi, GuanQun Liu, Prabar K. Ghosh, Fengchun Ye, Kien Nguyen, et al. (+11)
238 [GO] 2023―Jun―09 Persistent serum protein signatures define an inflammatory subcategory of long COVID Aarthi Talla, Suhas V. Vasaikar, Gregory Lee Szeto, Maria P. Lemos, Julie L. Czartoski, Hugh MacMillan, et al. (+14)
239 [GO] 2023―Jun―07 Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy Manon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, Aiste Dijokaite-Guraliuc, Raksha Das, Aekkachai Tuekprakhon, et al. (+20)
240 [GO] 2023―Jun―07 The preference signature of the SARS-CoV-2 Nucleocapsid NTD for its 5’-genomic RNA elements Sophie Marianne Korn, Karthikeyan Dhamotharan, Cy M. Jeffries, Andreas Schlundt
241 [GO] 2023―Jun―06 Estimating the impact of COVID-19 vaccine inequities: a modeling study Nicolò Gozzi, Matteo Chinazzi, Natalie E. Dean, Ira M. Longini Jr, M. Elizabeth Halloran, Nicola Perra, Alessandro Vespignani
242 [GO] 2023―Jun―06 GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults Christine D. Palmer, Ciaran D. Scallan, Lauren D. Kraemer Tardif, Melissa A. Kachura, Amy R. Rappaport, Daniel O. Koralek, et al. (+20)
243 [GO] 2023―Jun―05 Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2 Laura Heydemann, Małgorzata Ciurkiewicz, Georg Beythien, Kathrin Becker, Klaus Schughart, Stephanie Stanelle-Bertram, et al. (+9)
244 [GO] 2023―Jun―03 Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants Ana S. Gonzalez-Reiche, Hala Alshammary, Sarah Schaefer, Gopi Patel, Jose Polanco, Juan Manuel Carreño, et al. (+36)
245 [GO] 2023―May―29 Evidence-driven spatiotemporal COVID-19 hospitalization prediction with Ising dynamics Junyi Gao, Joerg Heintz, Christina Mack, Lucas Glass, Adam Cross, Jimeng Sun
246 [GO] 2023―May―25 A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8 Bruno A. Rodriguez-Rodriguez, Grace O. Ciabattoni, Ralf Duerr, Ana M. Valero-Jimenez, Stephen T. Yeung, Keaton M. Crosse, et al. (+13)
247 [GO] 2023―May―24 Long-term exposure to air pollution and severe COVID-19 in Catalonia: a population-based cohort study Otavio Ranzani, Anna Alari, Sergio Olmos, Carles Milà, Alex Rico, Joan Ballester, et al. (+13)
248 [GO] 2023―May―24 Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion Tabea M. Eser, Olga Baranov, Manuel Huth, Mohammed I. M. Ahmed, Flora Deák, Kathrin Held, et al. (+21)
249 [GO] 2023―May―23 Comparative mRNA booster effectiveness against death or hospitalization with COVID-19 pneumonia across at-risk US Veteran populations J. Daniel Kelly, Samuel Leonard, W. John Boscardin, Katherine J. Hoggatt, Emily N. Lum, Charles C. Austin, et al. (+5)
250 [GO] 2023―May―23 An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants Wanbo Tai, Shengyong Feng, Benjie Chai, Shuaiyao Lu, Guangyu Zhao, Dong Chen, et al. (+12)
251 [GO] 2023―May―22 Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program M. Daniel Brannock, Robert F. Chew, Alexander J. Preiss, Emily C. Hadley, Signe Redfield, Julie A. McMurry, et al. (+16)
252 [GO] 2023―May―19 saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern Mai Komori, Takuto Nogimori, Amber L. Morey, Takashi Sekida, Keiko Ishimoto, Matthew R. Hassett, et al. (+12)
253 [GO] 2023―May―17 Enabling accurate and early detection of recently emerged SARS-CoV-2 variants of concern in wastewater Nicolae Sapoval, Yunxi Liu, Esther G. Lou, Loren Hopkins, Katherine B. Ensor, Rebecca Schneider, et al. (+2)
254 [GO] 2023―May―16 Modelling the economic burden of SARS-CoV-2 infection in health care workers in four countries Huihui Wang, Wu Zeng, Kenneth Munge Kabubei, Jennifer J. K. Rasanathan, Jacob Kazungu, Sandile Ginindza, et al. (+9)
255 [GO] 2023―May―16 Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK Jia Wei, Philippa C. Matthews, Nicole Stoesser, John N. Newton, Ian Diamond, Ruth Studley, et al. (+71)
256 [GO] 2023―May―16 Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants Tomokazu Tamura, Jumpei Ito, Keiya Uriu, Jiri Zahradnik, Izumi Kida, Yuki Anraku, et al. (+79)
257 [GO] 2023―May―11 Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant Jumpei Ito, Rigel Suzuki, Keiya Uriu, Yukari Itakura, Jiri Zahradnik, Kanako Terakado Kimura, et al. (+75)
258 [GO] 2023―May―10 Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants Hong Lei, Aqu Alu, Jingyun Yang, Xi He, Cai He, Wenyan Ren, et al. (+13)
259 [GO] 2023―May―05 Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation Yafeng Li, Jessica S. Hook, Qing Ding, Xue Xiao, Stephen S. Chung, Marcel Mettlen, et al. (+3)
260 [GO] 2023―May―03 Detergent modulates the conformational equilibrium of SARS-CoV-2 Spike during cryo-EM structural determination Shawn B. Egri, Xue Wang, Marco A. Díaz-Salinas, Jeremy Luban, Natalya V. Dudkina, James B. Munro, Kuang Shen
261 [GO] 2023―Apr―27 Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong Ruopeng Xie, Kimberly M. Edwards, Dillon C. Adam, Kathy S. M. Leung, Tim K. Tsang, Shreya Gurung, et al. (+15)
262 [GO] 2023―Apr―25 Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils Einav Tayeb-Fligelman, Jeannette T. Bowler, Christen E. Tai, Michael R. Sawaya, Yi Xiao Jiang, Gustavo Garcia, et al. (+22)
263 [GO] 2023―Apr―25 Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin Pawel M. Wydorski, Jerzy Osipiuk, Benjamin T. Lanham, Christine Tesar, Michael Endres, Elizabeth Engle, et al. (+7)
264 [GO] 2023―Apr―24 Sample-to-answer platform for the clinical evaluation of COVID-19 using a deep learning-assisted smartphone-based assay Seungmin Lee, Sunmok Kim, Dae Sung Yoon, Jeong Soo Park, Hyowon Woo, Dongho Lee, et al. (+5)
265 [GO] 2023―Apr―22 Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19 Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, Nino Stocker, Anja Heider, Patrick Westermann, et al. (+19)
266 [GO] 2023―Apr―21 Behavioral changes during the COVID-19 pandemic decreased income diversity of urban encounters Takahiro Yabe, Bernardo García Bulle Bueno, Xiaowen Dong, Alex Pentland, Esteban Moro
267 [GO] 2023―Apr―21 Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6 Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, Takako Tabata, Keith Walcott, Gabriella R. Kimmerly, et al. (+13)
268 [GO] 2023―Apr―21 Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice Eakachai Prompetchara, Chutitorn Ketloy, Mohamad-Gabriel Alameh, Kittipan Tharakhet, Papatsara Kaewpang, Nongnaphat Yostrerat, et al. (+16)
269 [GO] 2023―Apr―20 Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase Jan Silhan, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, et al. (+3)
270 [GO] 2023―Apr―19 Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S. Bernardo García-Carreras, Matt D. T. Hitchings, Michael A. Johansson, Matthew Biggerstaff, Rachel B. Slayton, Jessica M. Healy, et al. (+5)
271 [GO] 2023―Apr―19 Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages Mark Chernyshev, Mrunal Sakharkar, Ruth I. Connor, Haley L. Dugan, Daniel J. Sheward, C. G. Rappazzo, et al. (+7)
272 [GO] 2023―Apr―17 A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates Payton A.-B. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S. Arunachalam, Mengyun Hu, et al. (+14)
273 [GO] 2023―Apr―17 Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants Yubin Liu, Ziyi Wang, Xinyu Zhuang, Shengnan Zhang, Zhicheng Chen, Yan Zou, et al. (+18)
274 [GO] 2023―Apr―15 Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19 Meng Yu, Afandi Charles, Alberto Cagigi, Wanda Christ, Björn Österberg, Sara Falck-Jones, et al. (+22)
275 [GO] 2023―Apr―14 Drivers of SARS-CoV-2 testing behaviour: a modelling study using nationwide testing data in England Younjung Kim, Christl A. Donnelly, Pierre Nouvellet
276 [GO] 2023―Apr―14 Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment Rana Abdelnabi, Dirk Jochmans, Kim Donckers, Bettina Trüeb, Nadine Ebert, Birgit Weynand, et al. (+2)
277 [GO] 2023―Apr―12 An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters Shaofeng Deng, Ying Liu, Rachel Chun-Yee Tam, Pin Chen, Anna Jinxia Zhang, Bobo Wing-Yee Mok, et al. (+11)
278 [GO] 2023―Apr―11 Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes Ramandip Grewal, Lena Nguyen, Sarah A. Buchan, Sarah E. Wilson, Sharifa Nasreen, Peter C. Austin, et al. (+7)
279 [GO] 2023―Apr―11 Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas Ighor Arantes, Gonzalo Bello, Valdinete Nascimento, Victor Souza, Arlesson da Silva, Dejanane Silva, et al. (+17)
280 [GO] 2023―Apr―10 Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study Zhuoying Huang, Shuangfei Xu, Jiechen Liu, Linlin Wu, Jing Qiu, Nan Wang, et al. (+10)
281 [GO] 2023―Apr―10 Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient Lena Jaki, Sebastian Weigang, Lisa Kern, Stefanie Kramme, Antoni G. Wrobel, Andrea B. Grawitz, et al. (+18)
282 [GO] 2023―Apr―10 High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike Timothy J. C. Tan, Zongjun Mou, Ruipeng Lei, Wenhao O. Ouyang, Meng Yuan, Ge Song, et al. (+6)
283 [GO] 2023―Apr―07 Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques Laura Solforosi, Lea M. M. Costes, Jeroen T. B. M. Tolboom, Katherine McMahan, Tochi Anioke, David Hope, et al. (+19)
284 [GO] 2023―Apr―07 Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative Chengxi Zang, Yongkang Zhang, Jie Xu, Jiang Bian, Dmitry Morozyuk, Edward J. Schenck, et al. (+10)
285 [GO] 2023―Apr―06 TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques Amit A. Upadhyay, Elise G. Viox, Timothy N. Hoang, Arun K. Boddapati, Maria Pino, Michelle Y.-H. Lee, et al. (+22)
286 [GO] 2023―Apr―06 Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection Wenjuan Dong, Jing Wang, Lei Tian, Jianying Zhang, Erik W. Settles, Chao Qin, et al. (+18)
287 [GO] 2023―Apr―05 Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes Ramandip Grewal, Lena Nguyen, Sarah A. Buchan, Sarah E. Wilson, Sharifa Nasreen, Peter C. Austin, et al. (+7)
288 [GO] 2023―Apr―05 Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection Daan K. J. Pieren, Sebastián G. Kuguel, Joel Rosado, Alba G. Robles, Joan Rey-Cano, Cristina Mancebo, et al. (+4)
289 [GO] 2023―Apr―04 Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19 Samuel Druzak, Elizabeth Iffrig, Blaine R. Roberts, Tiantian Zhang, Kirby S. Fibben, Yumiko Sakurai, et al. (+28)
290 [GO] 2023―Mar―31 Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals Haogao Gu, Ahmed Abdul Q귮r, Pavithra Krishnan, Daisy Y. M. Ng, Lydia D. J. Chang, Gigi Y. Z. Liu, et al. (+5)
291 [GO] 2023―Mar―30 Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response André Santa Cruz, Ana Mendes-Frias, Marne Azarias-da-Silva, Sónia André, Ana Isabel Oliveira, Olga Pires, et al. (+16)
292 [GO] 2023―Mar―28 Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2 Brian C. Sanders, Suman Pokhrel, Audrey D. Labbe, Irimpan I. Mathews, Connor J. Cooper, Russell B. Davidson, et al. (+27)
293 [GO] 2023―Mar―27 Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England Vahé Nafilyan, Charlotte R. Bermingham, Isobel L. Ward, Jasper Morgan, Francesco Zaccardi, Kamlesh Khunti, et al. (+3)
294 [GO] 2023―Mar―26 Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Youyi Fong, Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo, et al. (+31)
295 [GO] 2023―Mar―26 Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, Sara Y. Tartof
296 [GO] 2023―Mar―26 An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition Gabriela Dias Noske, Yun Song, Rafaela Sachetto Fernandes, Rod Chalk, Haitem Elmassoudi, Lizbé Koekemoer, et al. (+5)
297 [GO] 2023―Mar―26 Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain Tomohiro Takano, Takashi Sato, Ryutaro Kotaki, Saya Moriyama, Shuetsu Fukushi, Masahiro Shinoda, et al. (+10)
298 [GO] 2023―Mar―24 Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis Deborah Cromer, Megan Steain, Arnold Reynaldi, Timothy E. Schlub, Shanchita R. Khan, Sarah C. Sasson, et al. (+3)
299 [GO] 2023―Mar―24 Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, Ravi Kant, Petja Salminen, Riku Fagerlund, et al. (+17)
300 [GO] 2023―Mar―23 Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates Ryuta Uraki, Shun Iida, Peter J. Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki-Horimoto, et al. (+24)
301 [GO] 2023―Mar―22 Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, et al. (+10)
302 [GO] 2023―Mar―14 Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, Dietmar Hammerschmid, Katie J. Doores, Richard T. Bradshaw, et al. (+7)
303 [GO] 2023―Mar―10 Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G. Anosova, Lu Li, Tim Tibbitts, et al. (+7)
304 [GO] 2023―Mar―09 SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity Jillian R. Jaycox, Carolina Lucas, Inci Yildirim, Yile Dai, Eric Y. Wang, Valter Monteiro, et al. (+12)
305 [GO] 2023―Mar―07 Long-term gastrointestinal outcomes of COVID-19 Evan Xu, Yan Xie, Ziyad Al-Aly
306 [GO] 2023―Mar―02 Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life Ousseny Zerbo, G. Thomas Ray, Bruce Fireman, Evan Layefsky, Kristin Goddard, Edwin Lewis, et al. (+4)
307 [GO] 2023―Mar―02 Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants James Logue, Robert M. Johnson, Nita Patel, Bin Zhou, Sonia Maciejewski, Bryant Foreman, et al. (+17)
308 [GO] 2023―Feb―28 Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase Sebenzile K. Myeni, Peter J. Bredenbeek, Robert C. M. Knaap, Tim J. Dalebout, Shessy Torres Morales, Igor A. Sidorov, et al. (+8)
309 [GO] 2023―Feb―28 CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection B. Vijayalakshmi Ayyar, Khalil Ettayebi, Wilhelm Salmen, Umesh C. Karandikar, Frederick H. Neill, Victoria R. Tenge, et al. (+5)
310 [GO] 2023―Feb―25 Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2 Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai, et al. (+29)
311 [GO] 2023―Feb―24 Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants Haisheng Yu, Banghui Liu, Yudi Zhang, Xijie Gao, Qian Wang, Haitao Xiang, et al. (+33)
312 [GO] 2023―Feb―22 Epidemiological impacts of the NHS COVID-19 app in England and Wales throughout its first year Michelle Kendall, Daphne Tsallis, Chris Wymant, Andrea Di Francia, Yakubu Balogun, Xavier Didelot, et al. (+2)
313 [GO] 2023―Feb―22 National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age Laura A. Magee, Erika Molteni, Vicky Bowyer, Jeffrey N. Bone, Harriet Boulding, Asma Khalil, et al. (+17)
314 [GO] 2023―Feb―20 Magnetically boosted 1D photoactive microswarm for COVID-19 face mask disruption Jeonghyo Kim, Carmen C. Mayorga-Martinez, Martin Pumera
315 [GO] 2023―Feb―20 Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes Taniya Bhardwaj, Kundlik Gadhave, Shivani K. Kapuganti, Prateek Kumar, Zacharias Faidon Brotzakis, Kumar Udit Saumya, et al. (+9)
316 [GO] 2023―Feb―13 Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria Idowu B. Olawoye, Paul E. Oluniyi, Judith U. Oguzie, Jessica N. Uwanibe, Tolulope A. Kayode, Testimony J. Olumade, et al. (+133)
317 [GO] 2023―Feb―13 Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, et al. (+14)
318 [GO] 2023―Feb―11 Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19 Ronja Mothes, Anna Pascual-Reguant, Ralf Koehler, Juliane Liebeskind, Alina Liebheit, Sandy Bauherr, et al. (+26)
319 [GO] 2023―Feb―10 The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England Matt J. Keeling, Samuel Moore, Bridget S. Penman, Edward M. Hill
320 [GO] 2023―Feb―08 Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2 Manon Venet, Margarida Sa Ribeiro, Elodie Décembre, Alicia Bellomo, Garima Joshi, Célia Nuovo, et al. (+11)
321 [GO] 2023―Feb―08 Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients Romain Rouet, Jake Y. Henry, Matt D. Johansen, Meghna Sobti, Harikrishnan Balachandran, David B. Langley, et al. (+21)
322 [GO] 2023―Feb―06 SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection Jernej Pušnik, Werner O. Monzon-Posadas, Jasmin Zorn, Kathrin Peters, Maximilian Baum, Hannah Proksch, et al. (+4)
323 [GO] 2023―Feb―04 Direct Cryo-ET observation of platelet deformation induced by SARS-CoV-2 spike protein Christopher Cyrus Kuhn, Nirakar Basnet, Satish Bodakuntla, Pelayo Alvarez-Brecht, Scott Nichols, Antonio Martinez-Sanchez, et al. (+5)
324 [GO] 2023―Feb―03 A scoping review of the impacts of COVID-19 physical distancing measures on vulnerable population groups Lili Li, Araz Taeihagh, Si Ying Tan
325 [GO] 2023―Feb―03 Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity Wei-Hung Chen, Agnes Hajduczki, Elizabeth J. Martinez, Hongjun Bai, Hanover Matz, Thomas M. Hill, et al. (+39)
326 [GO] 2023―Feb―02 High-depth sequencing characterization of viral dynamics across tissues in fatal COVID-19 reveals compartmentalized infection Erica Normandin, Melissa Rudy, Nikolaos Barkas, Stephen F. Schaffner, Zoe Levine, Robert F. Padera, et al. (+7)
327 [GO] 2023―Jan―19 Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19 Kara W. Chew, Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs, et al. (+19)
328 [GO] 2023―Jan―19 Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape Leander Witte, Viren A. Baharani, Fabian Schmidt, Zijun Wang, Alice Cho, Raphael Raspe, et al. (+9)
329 [GO] 2023―Jan―19 Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Youyi Fong, Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo, et al. (+31)
330 [GO] 2023―Jan―19 Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2 Kuan-Ying A. Huang, Xiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, Lisa Schimanski, Tiong Kit Tan, et al. (+13)
331 [GO] 2023―Jan―18 Impact of the Euro 2020 championship on the spread of COVID-19 Jonas Dehning, Sebastian B. Mohr, Sebastian Contreras, Philipp Dönges, Emil N. Iftekhar, Oliver Schulz, et al. (+2)
332 [GO] 2023―Jan―17 Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants Emily E. Bendall, Amy P. Callear, Amy Getz, Kendra Goforth, Drew Edwards, Arnold S. Monto, et al. (+2)
333 [GO] 2023―Jan―16 Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, Anne von Gottberg, Meredith L. McMorrow, Nicole Wolter, et al. (+19)
334 [GO] 2023―Jan―13 Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation Thiago Moreno L. Souza, Vagner D. Pinho, Cristina F. Setim, Carolina Q. Sacramento, Rodrigo Marcon, Natalia Fintelman-Rodrigues, et al. (+29)
335 [GO] 2023―Jan―12 Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa Elsa du Bruyn, Cari Stek, Remi Daroowala, Qonita Said-Hartley, Marvin Hsiao, Georgia Schafer, et al. (+46)
336 [GO] 2023―Jan―12 Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 Hung Fu Tseng, Bradley K. Ackerson, Katia J. Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, et al. (+11)
337 [GO] 2023―Jan―10 Author Correction: Inferring time-varying generation time, serial interval, and incubation period distributions for COVID-19 Dongxuan Chen, Yiu-Chung Lau, Xiao-Ke Xu, Lin Wang, Zhanwei Du, Tim K. Tsang, et al. (+5)
338 [GO] 2023―Jan―10 SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19 Oksana V. Stanevich, Evgeniia I. Alekseeva, Maria Sergeeva, Artem V. Fadeev, Kseniya S. Komissarova, Anna A. Ivanova, et al. (+20)
339 [GO] 2023―Jan―10 SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation Valentino Bezzerri, Valentina Gentili, Martina Api, Alessia Finotti, Chiara Papi, Anna Tamanini, et al. (+16)
340 [GO] 2023―Jan―09 Providing normative information increases intentions to accept a COVID-19 vaccine Alex Moehring, Avinash Collis, Kiran Garimella, M. Amin Rahimian, Sinan Aral, Dean Eckles
341 [GO] 2023―Jan―06 Direct and indirect effects of the COVID-19 pandemic on mortality in Switzerland Julien Riou, Anthony Hauser, Anna Fesser, Christian L. Althaus, Matthias Egger, Garyfallos Konstantinoudis
342 [GO] 2023―Jan―06 A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection Clara Calvert, Jade Carruthers, Cheryl Denny, Jack Donaghy, Lisa E. M. Hopcroft, Leanne Hopkins, et al. (+20)
343 [GO] 2023―Jan―04 B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response Emanuele Andreano, Ida Paciello, Giulio Pierleoni, Giulia Piccini, Valentina Abbiento, Giada Antonelli, et al. (+19)
344 [GO] 2023―Jan―03 Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar Adeel A. Butt, Mylai D. Guerrero, Elenor B. Canlas, Husni Al-Dwairi, Abeir Bakhiet Mohammed Ali Alimam, Abdur Rehman Mohamad, et al. (+8)
345 [GO] 2022―Dec―27 Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, et al. (+19)
346 [GO] 2022―Dec―26 Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19 Allison K. Maher, Katie L. Burnham, Emma M. Jones, Michelle M. H. Tan, Rocel C. Saputil, Laury Baillon, et al. (+12)
347 [GO] 2022―Dec―23 Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2 Xuanming Guo, Jianli Cao, Jian-Piao Cai, Jiayan Wu, Jiangang Huang, Pallavi Asthana, et al. (+16)
348 [GO] 2022―Dec―16 Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19 Hideki Ogura, Jin Gohda, Xiuyuan Lu, Mizuki Yamamoto, Yoshio Takesue, Aoi Son, et al. (+14)
349 [GO] 2022―Dec―15 Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence Jack S. Gisby, Norzawani B. Buang, Artemis Papadaki, Candice L. Clarke, Talat H. Malik, Nicholas Medjeral-Thomas, et al. (+11)
350 [GO] 2022―Dec―14 Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones Noemia S. Lima, Maryam Musayev, Timothy S. Johnston, Danielle A. Wagner, Amy R. Henry, Lingshu Wang, et al. (+50)
351 [GO] 2022―Dec―13 Inferring time-varying generation time, serial interval, and incubation period distributions for COVID-19 Dongxuan Chen, Yiu-Chung Lau, Xiao-Ke Xu, Lin Wang, Zhanwei Du, Tim K. Tsang, et al. (+5)
352 [GO] 2022―Dec―13 Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, et al. (+10)
353 [GO] 2022―Dec―12 Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England Freja Cordelia Møller Kirsebom, Nick Andrews, Ruchira Sachdeva, Julia Stowe, Mary Ramsay, Jamie Lopez Bernal
354 [GO] 2022―Dec―12 Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation Gi Uk Jeong, Hyung-Jun Kwon, Wern Hann Ng, Xiang Liu, Hyun Woo Moon, Gun Young Yoon, et al. (+14)
355 [GO] 2022―Dec―10 The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi Louisa L. Y. Chan, Danielle E. Anderson, Hong Sheng Cheng, Fransiskus Xaverius Ivan, Si Chen, Adrian E. Z. Kang, et al. (+15)
356 [GO] 2022―Dec―09 SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling Scott B. Biering, Francielle Tramontini Gomes de Sousa, Laurentia V. Tjang, Felix Pahmeier, Chi Zhu, Richard Ruan, et al. (+23)
357 [GO] 2022―Dec―07 Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 Nicolas de Prost, Etienne Audureau, Nicholas Heming, Elyanne Gault, Tài Pham, Amal Chaghouri, et al. (+37)
358 [GO] 2022―Dec―06 A call for immediate action to increase COVID-19 vaccination uptake to prepare for the third pandemic winter Cornelia Betsch, Philipp Schmid, Pierre Verger, Stephan Lewandowsky, Anna Soveri, Ralph Hertwig, et al. (+13)
359 [GO] 2022―Nov―30 Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants Karin Magnusson, Doris Tove Kristoffersen, Andrea Dell’Isola, Ali Kiadaliri, Aleksandra Turkiewicz, Jos Runhaar, et al. (+4)
360 [GO] 2022―Nov―28 High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection Eva-Maria Jacobsen, Dorit Fabricius, Magdalena Class, Fernando Topfstedt, Raquel Lorenzetti, Iga Janowska, et al. (+30)
361 [GO] 2022―Nov―27 Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial I’ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain, Aleksandra M. Rzeszutek, Jack Pilgrim, Katie Bullock, et al. (+28)
362 [GO] 2022―Nov―25 Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity Nikaïa Smith, Céline Possémé, Vincent Bondet, Jamie Sugrue, Liam Townsend, Bruno Charbit, et al. (+17)
363 [GO] 2022―Nov―25 Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples Thomas Liechti, Yaser Iftikhar, Massimo Mangino, Margaret Beddall, Charles W. Goss, Jane A. O’Halloran, et al. (+2)
364 [GO] 2022―Nov―25 Comparison of antibody responses to SARS-CoV-2 variants in Australian children Zheng Quan Toh, Nadia Mazarakis, Jill Nguyen, Rachel A. Higgins, Jeremy Anderson, Lien Anh Ha Do, et al. (+7)
365 [GO] 2022―Nov―23 Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain Edward Burn, Elena Roel, Andrea Pistillo, Sergio Fernández-Bertolín, Maria Aragón, Berta Raventós, et al. (+7)
366 [GO] 2022―Nov―23 Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom Edward Burn, Xintong Li, Antonella Delmestri, Nathan Jones, Talita Duarte-Salles, Carlen Reyes, et al. (+6)
367 [GO] 2022―Nov―19 Disparate impacts on online information access during the Covid-19 pandemic Jina Suh, Eric Horvitz, Ryen W. White, Tim Althoff
368 [GO] 2022―Nov―19 Electricity consumption variation versus economic structure during COVID-19 on metropolitan statistical areas in the US Jinning Wang, Fangxing Li, Hantao Cui, Qingxin Shi, Trey Mingee
369 [GO] 2022―Nov―19 Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections Bin Ju, Qing Fan, Miao Wang, Xuejiao Liao, Huimin Guo, Haiyan Wang, et al. (+3)
370 [GO] 2022―Nov―16 Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity Deanna M. Santer, Daniel Li, Yanal Ghosheh, Muhammad Atif Zahoor, Dhanvi Prajapati, Bettina E. Hansen, et al. (+3)
371 [GO] 2022―Nov―16 XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection Pehuén Pereyra Gerber, Maria J. Donde, Nicholas J. Matheson, Alexander I. Taylor
372 [GO] 2022―Nov―16 Global disparities in SARS-CoV-2 genomic surveillance Anderson F. Brito, Elizaveta Semenova, Gytis Dudas, Gabriel W. Hassler, Chaney C. Kalinich, Moritz U. G. Kraemer, et al. (+200)
373 [GO] 2022―Nov―16 Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1 Alief Moulana, Thomas Dupic, Angela M. Phillips, Jeffrey Chang, Serafina Nieves, Anne A. Roffler, et al. (+4)
374 [GO] 2022―Nov―15 Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel Joshua Guedalia, Michal Lipschuetz, Ronit Calderon-Margalit, Sarah M. Cohen, Debra Goldman-Wohl, Tali Kaminer, et al. (+6)
375 [GO] 2022―Nov―15 Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice Anneliese S. Ashhurst, Matt D. Johansen, Joshua W. C. Maxwell, Skye Stockdale, Caroline L. Ashley, Anupriya Aggarwal, et al. (+12)
376 [GO] 2022―Nov―14 Reply to: The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein Mohammed Samer Shaban, Christin Müller, Christin Mayr-Buro, Hendrik Weiser, M. Lienhard Schmitz, John Ziebuhr, Michael Kracht
377 [GO] 2022―Nov―14 The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein Woo-Jin Shin, Dat P. Ha, Keigo Machida, Amy S. Lee
378 [GO] 2022―Nov―14 Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies Lucy B. Cook, Gillian O’Dell, Eleni Vourvou, Renuka Palanicawandar, Sasha Marks, Dragana Milojkovic, et al. (+12)
379 [GO] 2022―Nov―12 Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19 Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Nathalie Charland, Aurélien Lorin, Matthew P. Cheng, et al. (+8)
380 [GO] 2022―Nov―11 Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England Matthew Whitaker, Joshua Elliott, Barbara Bodinier, Wendy Barclay, Helen Ward, Graham Cooke, et al. (+3)
381 [GO] 2022―Nov―11 A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain Ji Wang, Caiguangxi Deng, Ming Liu, Yihao Liu, Liubing Li, Zhangping Huang, et al. (+8)
382 [GO] 2022―Nov―10 Development and validation of self-monitoring auto-updating prognostic models of survival for hospitalized COVID-19 patients Todd J. Levy, Kevin Coppa, Jinxuan Cang, Douglas P. Barnaby, Marc D. Paradis, Stuart L. Cohen, et al. (+6)
383 [GO] 2022―Nov―10 Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome Qin Liu, Qi Su, Fen Zhang, Hein M. Tun, Joyce Wing Yan Mak, Grace Chung-Yan Lui, et al. (+10)
384 [GO] 2022―Nov―10 Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters Shufeng Liu, Charles B. Stauft, Prabhuanand Selvaraj, Prabha Chandrasekaran, Felice D’Agnillo, Chao-Kai Chou, et al. (+7)
385 [GO] 2022―Nov―07 Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection Yonatan Woodbridge, Sharon Amit, Amit Huppert, Naama M. Kopelman
386 [GO] 2022―Nov―04 Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters Sapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, Winnie Kerstens, Madina Rasulova, Lindsey Bervoets, et al. (+12)
387 [GO] 2022―Nov―03 Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure Matthew R. Stutz, Nicholas P. Dylla, Steven D. Pearson, Paola Lecompte-Osorio, Ravi Nayak, Maryam Khalid, et al. (+21)
388 [GO] 2022―Nov―01 Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia Lucie Bernard-Raichon, Mericien Venzon, Jon Klein, Jordan E. Axelrad, Chenzhen Zhang, Alexis P. Sullivan, et al. (+80)
389 [GO] 2022―Oct―29 Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border Jordan Douglas, David Winter, Andrea McNeill, Sam Carr, Michael Bunce, Nigel French, et al. (+4)
390 [GO] 2022―Oct―27 Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3 Srividhya Swaminathan, Katie E. Lineburg, Archana Panikkar, Jyothy Raju, Lawton D. Murdolo, Christopher Szeto, et al. (+11)
391 [GO] 2022―Oct―26 Ultrafast one-minute electronic detection of SARS-CoV-2 infection by 3CLpro enzymatic activity in untreated saliva samples Ella Borberg, Eran Granot, Fernando Patolsky
392 [GO] 2022―Oct―23 Contact tracing reveals community transmission of COVID-19 in New York City Sen Pei, Sasikiran Kandula, Jaime Cascante Vega, Wan Yang, Steffen Foerster, Corinne Thompson, et al. (+6)
393 [GO] 2022―Oct―23 Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France Antonin Bal, Bruno Simon, Gregory Destras, Richard Chalvignac, Quentin Semanas, Antoine Oblette, et al. (+7)
394 [GO] 2022―Oct―23 Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine Dapeng Li, David R. Martinez, Alexandra Schäfer, Haiyan Chen, Maggie Barr, Laura L. Sutherland, et al. (+38)
395 [GO] 2022―Oct―21 Author Correction: Organ-specific genome diversity of replication-competent SARS-CoV-2 Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, Amélie Dendooven, Valentino D’Onofrio, Liesbeth Couck, et al. (+17)
396 [GO] 2022―Oct―18 Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial Olli P. O. Nevalainen, Saana Horstia, Sanna Laakkonen, Jarno Rutanen, Jussi M. J. Mustonen, Ilkka E. J. Kalliala, et al. (+53)
397 [GO] 2022―Oct―17 A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection Clara Calvert, Jade Carruthers, Cheryl Denny, Jack Donaghy, Sam Hillman, Lisa E. M. Hopcroft, et al. (+22)
398 [GO] 2022―Oct―17 SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa Adam Abdullahi, David Oladele, Michael Owusu, Steven A. Kemp, James Ayorinde, Abideen Salako, et al. (+37)
399 [GO] 2022―Oct―15 Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways Naoko Iwata-Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, Takashi Okura, Maino Tahara, Shuetsu Fukushi, et al. (+10)
400 [GO] 2022―Oct―15 Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern Danique M. H. van Rijswijck, Albert Bondt, Max Hoek, Karlijn van der Straten, Tom G. Caniels, Meliawati Poniman, et al. (+6)
401 [GO] 2022―Oct―13 Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Yang Liu, Xianwen Zhang, Jianying Liu, Hongjie Xia, Jing Zou, Antonio E. Muruato, et al. (+13)
402 [GO] 2022―Oct―13 Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England H. H. Webster, T. Nyberg, M. A. Sinnathamby, N. Abdul Aziz, N. Ferguson, G. Seghezzo, et al. (+12)
403 [GO] 2022―Oct―12 Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 Nicolas de Prost, Etienne Audureau, Nicholas Heming, Elyanne Gault, Tài Pham, Amal Chaghouri, et al. (+37)
404 [GO] 2022―Oct―12 Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort Michael A. Horberg, Eric Watson, Mamta Bhatia, Celeena Jefferson, Julia M. Certa, Seohyun Kim, et al. (+4)
405 [GO] 2022―Oct―12 Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity Claudia Kedor, Helma Freitag, Lil Meyer-Arndt, Kirsten Wittke, Leif G. Hanitsch, Thomas Zoller, et al. (+13)
406 [GO] 2022―Oct―08 Trends in non-COVID-19 hospitalizations prior to and during the COVID-19 pandemic period, United States, 2017-2021 Kelsie Cassell, Casey M. Zipfel, Shweta Bansal, Daniel M. Weinberger
407 [GO] 2022―Oct―07 The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype G. Tuba Barut, Nico Joel Halwe, Adriano Taddeo, Jenna N. Kelly, Jacob Schön, Nadine Ebert, et al. (+38)
408 [GO] 2022―Oct―06 Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil Otavio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, Giovanny V. A. de França, Cássia de Fátima R. Fernandes, Margaret L. Lind, et al. (+11)
409 [GO] 2022―Oct―06 DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2 Elizabeth M. Parzych, Jianqiu Du, Ali R. Ali, Katherine Schultheis, Drew Frase, Trevor R. F. Smith, et al. (+26)
410 [GO] 2022―Oct―05 Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants Claudia Del Vecchio, Bethan Cracknell Daniels, Giuseppina Brancaccio, Alessandra Rosalba Brazzale, Enrico Lavezzo, Constanze Ciavarella, et al. (+9)
411 [GO] 2022―Oct―04 Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa Nicole Wolter, Waasila Jassat, Sibongile Walaza, Richard Welch, Harry Moultrie, Michelle J. Groome, et al. (+23)
412 [GO] 2022―Oct―03 IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern Matthew R. Chang, Luke Tomasovic, Natalia A. Kuzmina, Adam J. Ronk, Patrick O. Byrne, Rebecca Johnson, et al. (+19)
413 [GO] 2022―Oct―02 Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study Madhumita Shrotri, Ellen Fragaszy, Vincent Nguyen, Annalan M. D. Navaratnam, Cyril Geismar, Sarah Beale, et al. (+10)
414 [GO] 2022―Sep―30 Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study Julia Stowe, Nick Andrews, Freja Kirsebom, Mary Ramsay, Jamie Lopez Bernal
415 [GO] 2022―Sep―30 Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark Frederik Plesner Lyngse, Carsten Thure Kirkeby, Matthew Denwood, Lasse Engbo Christiansen, Kåre Mølbak, Camilla Holten Møller, et al. (+13)
416 [GO] 2022―Sep―29 SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner Tatiana Dandolini Saccon, Felippe Mousovich-Neto, Raissa Guimarães Ludwig, Victor Corasolla Carregari, Ana Beatriz dos Anjos Souza, Amanda Stephane Cruz dos Passos, et al. (+43)
417 [GO] 2022―Sep―29 Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants Neda Jalali, Hilde K. Brustad, Arnoldo Frigessi, Emily A. MacDonald, Hinta Meijerink, Siri L. Feruglio, et al. (+4)
418 [GO] 2022―Sep―28 Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland Gudmundur L. Norddahl, Pall Melsted, Kristbjorg Gunnarsdottir, Gisli H. Halldorsson, Thorunn A. Olafsdottir, Arnaldur Gylfason, et al. (+7)
419 [GO] 2022―Sep―26 Circulating multimeric immune complexes contribute to immunopathology in COVID-19 Jakob Ankerhold, Sebastian Giese, Philipp Kolb, Andrea Maul-Pavicic, Reinhard E. Voll, Nathalie Göppert, et al. (+14)
420 [GO] 2022―Sep―23 Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data Rhys P. D. Inward, Kris V. Parag, Nuno R. Faria
421 [GO] 2022―Sep―23 Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection Elham Khatamzas, Markus H. Antwerpen, Alexandra Rehn, Alexander Graf, Johannes Christian Hellmuth, Alexandra Hollaus, et al. (+24)
422 [GO] 2022―Sep―23 Household transmission of the SARS-CoV-2 Omicron variant in Denmark Frederik Plesner Lyngse, Laust Hvas Mortensen, Matthew J. Denwood, Lasse Engbo Christiansen, Camilla Holten Møller, Robert Leo Skov, et al. (+13)
423 [GO] 2022―Sep―22 Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth Zhiqiang Ku, Xuping Xie, Jianqing Lin, Peng Gao, Bin Wu, Abbas El Sahili, et al. (+19)
424 [GO] 2022―Sep―22 Tracking changes in SARS-CoV-2 transmission with a novel outpatient sentinel surveillance system in Chicago, USA Reese Richardson, Emile Jorgensen, Philip Arevalo, Tobias M. Holden, Katelyn M. Gostic, Massimo Pacilli, et al. (+4)
425 [GO] 2022―Sep―21 Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity Martin J. Scurr, George Lippiatt, Lorenzo Capitani, Kirsten Bentley, Sarah N. Lauder, Kathryn Smart, et al. (+6)
426 [GO] 2022―Sep―21 The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition Chihiro Motozono, Mako Toyoda, Toong Seng Tan, Hiroshi Hamana, Yoshihiko Goto, Yoshiki Aritsu, et al. (+8)
427 [GO] 2022―Sep―20 Publishing a pandemic
428 [GO] 2022―Sep―17 A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19 Chih-Jung Chen, Lan-Yan Yang, Wei-Yang Chang, Yhu-Chering Huang, Cheng-Hsun Chiu, Shin-Ru Shih, et al. (+2)
429 [GO] 2022―Sep―12 Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial Daniel Mrak, Daniela Sieghart, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, et al. (+36)
430 [GO] 2022―Sep―12 Reply to: Machine-learning prediction of hosts of novel coronaviruses requires caution as it may affect wildlife conservation Marcus S. C. Blagrove, Matthew Baylis, Maya Wardeh
431 [GO] 2022―Sep―12 Machine-learning prediction of hosts of novel coronaviruses requires caution as it may affect wildlife conservation Sophie Lund Rasmussen, Cino Pertoldi, David W. Macdonald
432 [GO] 2022―Sep―08 The impact of repeated rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2 Tigist F. Menkir, Christl A. Donnelly
433 [GO] 2022―Sep―08 Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro Mikhail A. Hameedi, Erica T. Prates, Michael R. Garvin, Irimpan I. Mathews, B. Kirtley Amos, Omar Demerdash, et al. (+12)
434 [GO] 2022―Sep―08 Publisher Correction: Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections Qinghong Fan, Jingrong Shi, Yanhong Yang, Guofang Tang, Mengling Jiang, Jiaojiao Li, et al. (+24)
435 [GO] 2022―Sep―06 Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine Nozomi Kuse, Yu Zhang, Takayuki Chikata, Hung The Nguyen, Shinichi Oka, Hiroyuki Gatanaga, Masafumi Takiguchi
436 [GO] 2022―Sep―06 Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus Ana A. Weil, Kyle G. Luiten, Amanda M. Casto, Julia C. Bennett, Jessica O’Hanlon, Peter D. Han, et al. (+23)
437 [GO] 2022―Sep―06 Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes Shanlin Ke, Scott T. Weiss, Yang-Yu Liu
438 [GO] 2022―Sep―03 Interrupted-time-series analysis of the immediate impact of COVID-19 mitigation measures on preterm birth in China Yanxia Xie, Yi Mu, Peiran Chen, Zheng Liu, Yanping Wang, Qi Li, et al. (+3)
439 [GO] 2022―Sep―03 Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy Shouheng Jin, Xing He, Ling Ma, Zhen Zhuang, Yiliang Wang, Meng Lin, et al. (+13)
440 [GO] 2022―Sep―03 X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation Jaeyong Lee, Calem Kenward, Liam J. Worrall, Marija Vuckovic, Francesco Gentile, Anh-Tien Ton, et al. (+4)
441 [GO] 2022―Sep―01 SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals Kaori Sano, Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason, et al. (+23)
442 [GO] 2022―Aug―30 Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategy Victoria N. Parikh, Alexander G. Ioannidis, David Jimenez-Morales, John E. Gorzynski, Hannah N. De Jong, Xiran Liu, et al. (+64)
443 [GO] 2022―Aug―30 Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates Romain Marlin, Delphine Desjardins, Vanessa Contreras, Guillaume Lingas, Caroline Solas, Pierre Roques, et al. (+21)
444 [GO] 2022―Aug―30 A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity C. Kedor, H. Freitag, L. Meyer-Arndt, K. Wittke, L. G. Hanitsch, T. Zoller, et al. (+13)
445 [GO] 2022―Aug―26 Call for a unified approach to Monkeypox infection in pregnancy: Lessons from the COVID-19 pandemic Asma Khalil, Athina Samara, Pat O’Brien, Shamez Ladhani
446 [GO] 2022―Aug―24 Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape Zhennan Zhao, Jingya Zhou, Mingxiong Tian, Min Huang, Sheng Liu, Yufeng Xie, et al. (+16)
447 [GO] 2022―Aug―22 Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19 Kara W. Chew, Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs, et al. (+19)
448 [GO] 2022―Aug―22 The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force Qingbo S. Wang, Ryuya Edahiro, Ho Namkoong, Takanori Hasegawa, Yuya Shirai, Kyuto Sonehara, et al. (+437)
449 [GO] 2022―Aug―22 Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV Alessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, Giulia Matusali, Veronica Bordoni, Simone Lanini, et al. (+54)
450 [GO] 2022―Aug―22 Comparison of the 2021 COVID-19 roadmap projections against public health data in England Matt J. Keeling, Louise Dyson, Michael J. Tildesley, Edward M. Hill, Samuel Moore
451 [GO] 2022―Aug―20 Designing isolation guidelines for COVID-19 patients with rapid antigen tests Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Woo Joohyeon, Shoya Iwanami, Yasuhisa Fujita, et al. (+6)
452 [GO] 2022―Aug―19 Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era Rosanna C. Barnard, Nicholas G. Davies, James D. Munday, Rachel Lowe, Gwenan M. Knight, Quentin J. Leclerc, et al. (+54)
453 [GO] 2022―Aug―18 BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19 Georg M. N. Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V. Stankov, Ivan Odak, et al. (+22)
454 [GO] 2022―Aug―18 SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort Robert W. Aldridge, Alexei Yavlinsky, Vincent Nguyen, Max T. Eyre, Madhumita Shrotri, Annalan M. D. Navaratnam, et al. (+11)
455 [GO] 2022―Aug―18 SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization Dhiraj Mannar, James W. Saville, Zehua Sun, Xing Zhu, Michelle M. Marti, Shanti S. Srivastava, et al. (+13)
456 [GO] 2022―Aug―17 Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study Peter D. Kirwan, Andre Charlett, Paul Birrell, Suzanne Elgohari, Russell Hope, Sema Mandal, et al. (+2)
457 [GO] 2022―Aug―17 Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein Julia T. Castro, Patrick Azevedo, Marcílio J. Fumagalli, Natalia S. Hojo-Souza, Natalia Salazar, Gregório G. Almeida, et al. (+27)
458 [GO] 2022―Aug―15 ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19 Maik Pietzner, Robert Lorenz Chua, Eleanor Wheeler, Katharina Jechow, Julian D. S. Willett, Helena Radbruch, et al. (+13)
459 [GO] 2022―Aug―15 Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland Colin R. Simpson, Steven Kerr, Srinivasa Vittal Katikireddi, Colin McCowan, Lewis D. Ritchie, Jiafeng Pan, et al. (+9)
460 [GO] 2022―Aug―15 Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions Edyth Parker, Catelyn Anderson, Mark Zeller, Ahmad Tibi, Jennifer L. Havens, Geneviève Laroche, et al. (+24)
461 [GO] 2022―Aug―15 Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, et al. (+23)
462 [GO] 2022―Aug―13 Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period Pilar T. V. Florentino, Flávia J. O. Alves, Thiago Cerqueira-Silva, Vinicius de Araújo Oliveira, Juracy B. S. Júnior, Adelson G. Jantsch, et al. (+8)
463 [GO] 2022―Aug―13 Empirical evidence on the efficiency of backward contact tracing in COVID-19 Joren Raymenants, Caspar Geenen, Jonathan Thibaut, Klaas Nelissen, Sarah Gorissen, Emmanuel Andre
464 [GO] 2022―Aug―12 Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C Juanjie Tang, Tanya Novak, Julian Hecker, Gabrielle Grubbs, Fatema Tuz Zahra, Lorenza Bellusci, et al. (+33)
465 [GO] 2022―Aug―12 Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, Caroline van den Ende, Noortje van Maarseveen, Lubna Ali, et al. (+7)
466 [GO] 2022―Aug―11 Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens Verena Klemis, Tina Schmidt, David Schub, Janine Mihm, Stefanie Marx, Amina Abu-Omar, et al. (+10)
467 [GO] 2022―Aug―11 SARS-CoV-2 and other respiratory pathogens are detected in continuous air samples from congregate settings Mitchell D. Ramuta, Christina M. Newman, Savannah F. Brakefield, Miranda R. Stauss, Roger W. Wiseman, Amanda Kita-Yarbro, et al. (+22)
468 [GO] 2022―Aug―10 Science in the time of COVID-19: Reflections on the UK Events Research Programme Theresa M. Marteau, Michael J. Parker, W. John Edmunds
469 [GO] 2022―Aug―09 A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia Cecilia A. Sánchez, Hongying Li, Kendra L. Phelps, Carlos Zambrana-Torrelio, Lin-Fa Wang, Peng Zhou, et al. (+3)
470 [GO] 2022―Aug―09 A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples Yanan Tang, Turun Song, Lu Gao, Saifu Yin, Ming Ma, Yun Tan, et al. (+5)
471 [GO] 2022―Aug―08 COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation Matthias Reinscheid, Hendrik Luxenburger, Vivien Karl, Anne Graeser, Sebastian Giese, Kevin Ciminski, et al. (+19)
472 [GO] 2022―Aug―08 Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination Lorenza Bellusci, Gabrielle Grubbs, Fatema Tuz Zahra, David Forgacs, Hana Golding, Ted M. Ross, Surender Khurana
473 [GO] 2022―Aug―08 ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants Neeltje van Doremalen, Jonathan E. Schulz, Danielle R. Adney, Taylor A. Saturday, Robert J. Fischer, Claude Kwe Yinda, et al. (+11)
474 [GO] 2022―Aug―06 Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection Guillermo Barturen, Elena Carnero-Montoro, Manuel Martínez-Bueno, Silvia Rojo-Rello, Beatriz Sobrino, Óscar Porras-Perales, et al. (+3)
475 [GO] 2022―Aug―05 Structure of SARS-CoV-2 membrane protein essential for virus assembly Zhikuan Zhang, Norimichi Nomura, Yukiko Muramoto, Toru Ekimoto, Tomoko Uemura, Kehong Liu, et al. (+8)
476 [GO] 2022―Aug―04 A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike Mathieu Claireaux, Tom G. Caniels, Marlon de Gast, Julianna Han, Denise Guerra, Gius Kerster, et al. (+27)
477 [GO] 2022―Aug―03 An intranasal ASO therapeutic targeting SARS-CoV-2 Chi Zhu, Justin Y. Lee, Jia Z. Woo, Lei Xu, Xammy Nguyenla, Livia H. Yamashiro, et al. (+17)
478 [GO] 2022―Aug―03 Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England Paul Elliott, Oliver Eales, Barbara Bodinier, David Tang, Haowei Wang, Jakob Jonnerby, et al. (+16)
479 [GO] 2022―Aug―02 Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes Samah Hayek, Yatir Ben-shlomo, Noa Dagan, Ben Y. Reis, Noam Barda, Eldad Kepten, et al. (+6)
480 [GO] 2022―Aug―01 Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections Nina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Lene Surland Knudsen, et al. (+20)
481 [GO] 2022―Jul―29 SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model Carolin M. Lieber, Robert M. Cox, Julien Sourimant, Josef D. Wolf, Kate Juergens, Quynh Phung, et al. (+9)
482 [GO] 2022―Jul―29 A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions Yang Liu, Xianwen Zhang, Jianying Liu, Hongjie Xia, Jing Zou, Antonio E. Muruato, et al. (+13)
483 [GO] 2022―Jul―28 Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England Oliver Eales, Leonardo de Oliveira Martins, Andrew J. Page, Haowei Wang, Barbara Bodinier, David Tang, et al. (+13)
484 [GO] 2022―Jul―27 Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines Li Wang, Markus H. Kainulainen, Nannan Jiang, Han Di, Gaston Bonenfant, Lisa Mills, et al. (+78)
485 [GO] 2022―Jul―27 Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, et al. (+26)
486 [GO] 2022―Jul―25 An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence Mario Morvan, Anna Lo Jacomo, Celia Souque, Matthew J. Wade, Till Hoffmann, Koen Pouwels, et al. (+10)
487 [GO] 2022―Jul―25 Length-dependent motions of SARS-CoV-2 frameshifting RNA pseudoknot and alternative conformations suggest avenues for frameshifting suppression Shuting Yan, Qiyao Zhu, Swati Jain, Tamar Schlick
488 [GO] 2022―Jul―21 A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark Anna Irene Vedel Sørensen, Lampros Spiliopoulos, Peter Bager, Nete Munk Nielsen, Jørgen Vinsløv Hansen, Anders Koch, et al. (+3)
489 [GO] 2022―Jul―21 Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR Kenneth Danh, Donna Grace Karp, Malvika Singhal, Akshaya Tankasala, David Gebhart, Felipe de Jesus Cortez, et al. (+18)
490 [GO] 2022―Jul―20 A Bayesian approach to infer recombination patterns in coronaviruses Nicola F. Müller, Kathryn E. Kistler, Trevor Bedford
491 [GO] 2022―Jul―19 Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome Anahita Fathi, Christine Dahlke, Verena Krähling, Alexandra Kupke, Nisreen M. A. Okba, Matthijs P. Raadsen, et al. (+21)
492 [GO] 2022―Jul―18 Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, et al. (+11)
493 [GO] 2022―Jul―15 Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study Husam M. Salah, Marat Fudim, Shawn T. O’Neil, Amin Manna, Christopher G. Chute, Melissa C. Caughey
494 [GO] 2022―Jul―12 Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand Lauren Jelley, Jordan Douglas, Xiaoyun Ren, David Winter, Andrea McNeill, Sue Huang, et al. (+5)
495 [GO] 2022―Jul―09 Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections Qinghong Fan, Jingrong Shi, Yanhong Yang, Guofang Tang, Mengling Jiang, Jiaojiao Li, et al. (+24)
496 [GO] 2022―Jul―08 Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults Lior Rennert, Zichen Ma, Christopher S. McMahan, Delphine Dean
497 [GO] 2022―Jul―08 Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children Eran Mick, Alexandra Tsitsiklis, Natasha Spottiswoode, Saharai Caldera, Paula Hayakawa Serpa, Angela M. Detweiler, et al. (+16)
498 [GO] 2022―Jul―08 A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection Iris N. Pardieck, Tetje C. van der Sluis, Esmé T. I. van der Gracht, Dominique M. B. Veerkamp, Felix M. Behr, Suzanne van Duikeren, et al. (+20)
499 [GO] 2022―Jul―07 Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera Raveen Rathnasinghe, Sonia Jangra, Chengjin Ye, Anastasija Cupic, Gagandeep Singh, Carles Martínez-Romero, et al. (+41)
500 [GO] 2022―Jul―05 Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic Thandavarayan Ramamurthy, Agila Kumari Pragasam, Alyce Taylor-Brown, Robert C. Will, Karthick Vasudevan, Bhabatosh Das, et al. (+12)
501 [GO] 2022―Jul―04 Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs Meriem Bekliz, Kenneth Adea, Pauline Vetter, Christiane S. Eberhardt, Krisztina Hosszu-Fellous, Diem-Lan Vu, et al. (+10)
502 [GO] 2022―Jul―02 Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains James Brett Case, Samantha Mackin, John M. Errico, Zhenlu Chong, Emily A. Madden, Bradley Whitener, et al. (+19)
503 [GO] 2022―Jul―01 Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021 Jeffrey V. Lazarus, Katarzyna Wyka, Trenton M. White, Camila A. Picchio, Kenneth Rabin, Scott C. Ratzan, et al. (+3)
504 [GO] 2022―Jun―30 Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern Frederik Plesner Lyngse, Kåre Mølbak, Matt Denwood, Lasse Engbo Christiansen, Camilla Holten Møller, Morten Rasmussen, et al. (+7)
505 [GO] 2022―Jun―29 Author Correction: The SARS-CoV-2 spike protein is vulnerable to moderate electric fields Claudia R. Arbeitman, Pablo Rojas, Pedro Ojeda-May, Martin E. Garcia
506 [GO] 2022―Jun―29 SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection Jia Wei, Philippa C. Matthews, Nicole Stoesser, Ian Diamond, Ruth Studley, Emma Rourke, et al. (+72)
507 [GO] 2022―Jun―28 Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms Caroline G. Atyeo, Lydia L. Shook, Sara Brigida, Rose M. De Guzman, Stepan Demidkin, Cordelia Muir, et al. (+18)
508 [GO] 2022―Jun―28 Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, et al. (+23)
509 [GO] 2022―Jun―28 Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records Ellen J. Thompson, Dylan M. Williams, Alex J. Walker, Ruth E. Mitchell, Claire L. Niedzwiedz, Tiffany C. Yang, et al. (+60)
510 [GO] 2022―Jun―25 COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods Florian B. Mayr, Victor B. Talisa, Alexander D. Castro, Obaid S. Shaikh, Saad B. Omer, Adeel A. Butt
511 [GO] 2022―Jun―25 Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines Stéphane Le Vu, Marion Bertrand, Marie-Joelle Jabagi, Jérémie Botton, Jérôme Drouin, Bérangère Baricault, et al. (+3)
512 [GO] 2022―Jun―25 Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in children Felix Dewald, Isabelle Suárez, Ronja Johnen, Jan Grossbach, Roberto Moran-Tovar, Gertrud Steger, et al. (+51)
513 [GO] 2022―Jun―25 Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City Joel O. Wertheim, Jade C. Wang, Mindy Leelawong, Darren P. Martin, Jennifer L. Havens, Moinuddin A. Chowdhury, et al. (+18)
514 [GO] 2022―Jun―24 Author Correction: Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection Simon J. L. Petitjean, Wenzhang Chen, Melanie Koehler, Ravikumar Jimmidi, Jinsung Yang, Danahe Mohammed, et al. (+5)
515 [GO] 2022―Jun―23 A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge Biao Zhou, Runhong Zhou, Bingjie Tang, Jasper Fuk-Woo Chan, Mengxiao Luo, Qiaoli Peng, et al. (+18)
516 [GO] 2022―Jun―23 Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine Chaitanya Kurhade, Jing Zou, Hongjie Xia, Hui Cai, Qi Yang, Mark Cutler, et al. (+6)
517 [GO] 2022―Jun―21 Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses Zepeng Xu, Xinrui Kang, Pu Han, Pei Du, Linjie Li, Anqi Zheng, et al. (+6)
518 [GO] 2022―Jun―21 Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance Ala M. Shaqra, Sarah N. Zvornicanin, Qiu Yu J. Huang, Gordon J. Lockbaum, Mark Knapp, Laura Tandeske, et al. (+7)
519 [GO] 2022―Jun―20 SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters Federico Armando, Georg Beythien, Franziska K. Kaiser, Lisa Allnoch, Laura Heydemann, Malgorzata Rosiak, et al. (+9)
520 [GO] 2022―Jun―17 A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants Scotland E. Farley, Jennifer E. Kyle, Hans C. Leier, Lisa M. Bramer, Jules B. Weinstein, Timothy A. Bates, et al. (+4)
521 [GO] 2022―Jun―16 Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine Kevin J. Kramer, Erin M. Wilfong, Kelsey Voss, Sierra M. Barone, Andrea R. Shiakolas, Nagarajan Raju, et al. (+14)
522 [GO] 2022―Jun―14 Opportunities to tackle structural racism and ethnicity-based discrimination in recovering and rebuilding from the COVID-19 pandemic Natalia Linos, Mary T. Bassett, Alejandra Salemi, Margareta Matache, Konstantinos Tararas, Rodney Kort, et al. (+9)
523 [GO] 2022―Jun―13 Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19 Mirren Charnley, Saba Islam, Guneet K. Bindra, Jeremy Engwirda, Julian Ratcliffe, Jiangtao Zhou, et al. (+5)
524 [GO] 2022―Jun―13 Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees Emanuele Andreano, Ida Paciello, Silvia Marchese, Lorena Donnici, Giulio Pierleoni, Giulia Piccini, et al. (+13)
525 [GO] 2022―Jun―10 Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination Aloysious Ssemaganda, Huong Mai Nguyen, Faisal Nuhu, Naima Jahan, Catherine M. Card, Sandra Kiazyk, et al. (+11)
526 [GO] 2022―Jun―09 Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan, Farida Ismail Al Hosani, Omer Najim, Halah Ibrahim, et al. (+24)
527 [GO] 2022―Jun―09 Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine Tal Patalon, Yaki Saciuk, Asaf Peretz, Galit Perez, Yoav Lurie, Yasmin Maor, Sivan Gazit
528 [GO] 2022―Jun―09 Mitigation of SARS-CoV-2 transmission at a large public university Diana Rose E. Ranoa, Robin L. Holland, Fadi G. Alnaji, Kelsie J. Green, Leyi Wang, Richard L. Fredrickson, et al. (+143)
529 [GO] 2022―Jun―08 Rapid, adaptable and sensitive Cas13-based COVID-19 diagnostics using ADESSO Beatrice Casati, Joseph Peter Verdi, Alexander Hempelmann, Maximilian Kittel, Andrea Gutierrez Klaebisch, Bianca Meister, et al. (+12)
530 [GO] 2022―Jun―07 Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection Amy R. Rappaport, Sue-Jean Hong, Ciaran D. Scallan, Leonid Gitlin, Arvin Akoopie, Gregory R. Boucher, et al. (+9)
531 [GO] 2022―Jun―06 Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 Anna-Lisa Sorg, Leon Bergfeld, Marietta Jank, Victor Corman, Ilia Semmler, Anna Goertz, et al. (+25)
532 [GO] 2022―Jun―06 Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 Zhenhao Fang, Lei Peng, Renata Filler, Kazushi Suzuki, Andrew McNamara, Qianqian Lin, et al. (+13)
533 [GO] 2022―Jun―03 Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories Yong Ge, Wen-Bin Zhang, Xilin Wu, Corrine W. Ruktanonchai, Haiyan Liu, Jianghao Wang, et al. (+10)
534 [GO] 2022―Jun―02 Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Peter Coyle, Patrick Tang, Hadi M. Yassine, et al. (+18)
535 [GO] 2022―May―31 A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data Mahan Ghafari, Oliver J. Watson, Ariel Karlinsky, Luca Ferretti, Aris Katzourakis
536 [GO] 2022―May―31 Author Correction: SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters Wei Qiao, Hui En Lau, Huizhi Xie, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Hin Chu, et al. (+11)
537 [GO] 2022―May―27 Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C Juanjie Tang, Tanya Novak, Julian Hecker, Gabrielle Grubbs, Fatema Tuz Zahra, Lorenza Bellusci, et al. (+33)
538 [GO] 2022―May―27 Transmission of SARS-CoV-2 from humans to animals and potential host adaptation Cedric C. S. Tan, Su Datt Lam, Damien Richard, Christopher J. Owen, Dorothea Berchtold, Christine Orengo, et al. (+5)
539 [GO] 2022―May―26 Combining rapid antigen testing and syndromic surveillance improves community-based COVID-19 detection in a low-income country Fergus J. Chadwick, Jessica Clark, Shayan Chowdhury, Tasnuva Chowdhury, David J. Pascall, Yacob Haddou, et al. (+18)
540 [GO] 2022―May―26 Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2 Jing Zou, Chaitanya Kurhade, Hongjie Xia, Mingru Liu, Xuping Xie, Ping Ren, Pei-Yong Shi
541 [GO] 2022―May―26 SARS-CoV-2 accessory proteins reveal distinct serological signatures in children Asmaa Hachim, Haogao Gu, Otared Kavian, Masashi Mori, Mike Y. W. Kwan, Wai Hung Chan, et al. (+14)
542 [GO] 2022―May―26 SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5 Uddhav Timilsina, Supawadee Umthong, Emily B. Ivey, Brandon Waxman, Spyridon Stavrou
543 [GO] 2022―May―25 Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes Chunyan Wang, Emma L. Hesketh, Tatiana M. Shamorkina, Wentao Li, Peter J. Franken, Dubravka Drabek, et al. (+9)
544 [GO] 2022―May―24 Off-season RSV epidemics in Australia after easing of COVID-19 restrictions John-Sebastian Eden, Chisha Sikazwe, Ruopeng Xie, Yi-Mo Deng, Sheena G. Sullivan, Alice Michie, et al. (+27)
545 [GO] 2022―May―24 Competent immune responses to SARS-CoV-2 variants in older adults following two doses of mRNA vaccination Mladen Jergović, Jennifer L. Uhrlaub, Makiko Watanabe, Christine M. Bradshaw, Lisa M. White, Bonnie J. LaFleur, et al. (+5)
546 [GO] 2022―May―19 Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro Leiping Zeng, Yanxia Liu, Xammy Huu Nguyenla, Timothy R. Abbott, Mengting Han, Yanyu Zhu, et al. (+22)
547 [GO] 2022―May―19 SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity Wuji Zhang, Brendon Y. Chua, Kevin J. Selva, Lukasz Kedzierski, Thomas M. Ashhurst, Ebene R. Haycroft, et al. (+45)
548 [GO] 2022―May―19 SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status Kate M. Bubar, Casey E. Middleton, Kristen K. Bjorkman, Roy Parker, Daniel B. Larremore
549 [GO] 2022―May―18 Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance Rebecca J. Rockett, Jenny Draper, Mailie Gall, Eby M. Sim, Alicia Arnott, Jessica E. Agius, et al. (+19)
550 [GO] 2022―May―13 A broader perspective on the economics of malaria prevention and the potential impact of SARS-CoV-2 Elisa Sicuri, Francesco Ramponi, Iris Lopes-Rafegas, Francisco Saúte
551 [GO] 2022―May―13 Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant Fanglei Zuo, Hassan Abolhassani, Likun Du, Antonio Piralla, Federico Bertoglio, Leire de Campos-Mata, et al. (+22)
552 [GO] 2022―May―13 Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants Yin-Feng Kang, Cong Sun, Jing Sun, Chu Xie, Zhen Zhuang, Hui-Qin Xu, et al. (+6)
553 [GO] 2022―May―11 Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19 Ting Lu, Rui Ma, Wenjuan Dong, Kun-Yu Teng, Daniel S. Kollath, Zhiyao Li, et al. (+12)
554 [GO] 2022―May―11 Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany, Casper Rokx, Corine Geurtsvankessel, Grigorios Papageourgiou, et al. (+192)
555 [GO] 2022―May―10 Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy Smriti Prasad, Erkan Kalafat, Helena Blakeway, Rosemary Townsend, Pat O’Brien, Edward Morris, et al. (+8)
556 [GO] 2022―May―10 Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection Simon J. L. Petitjean, Wenzhang Chen, Melanie Koehler, Ravikumar Jimmidi, Jinsung Yang, Danahe Mohammed, et al. (+5)
557 [GO] 2022―May―10 Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B. C. Kopecky, et al. (+7)
558 [GO] 2022―May―10 Archival influenza virus genomes from Europe reveal genomic variability during the 1918 pandemic Livia V. Patrono, Bram Vrancken, Matthias Budt, Ariane Düx, Sebastian Lequime, Sengül Boral, et al. (+20)
559 [GO] 2022―May―09 SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters Wei Qiao, Hui En Lau, Huizhi Xie, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Hin Chu, et al. (+11)
560 [GO] 2022―May―06 Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021 Collins M. Morang’a, Joyce M. Ngoi, Jones Gyamfi, Dominic S. Y. Amuzu, Benjamin D. Nuertey, Philip M. Soglo, et al. (+50)
561 [GO] 2022―May―05 Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants Milja Belik, Pinja Jalkanen, Rickard Lundberg, Arttu Reinholm, Larissa Laine, Elina Väisänen, et al. (+19)
562 [GO] 2022―May―04 Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2 Isobel Routledge, Saki Takahashi, Adrienne Epstein, Jill Hakim, Owen Janson, Keirstinne Turcios, et al. (+9)
563 [GO] 2022―May―04 Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen Alice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher, Nathalie Arhel, Artem Baidaliuk, Sandie Munier, et al. (+19)
564 [GO] 2022―May―02 Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C Conor McCafferty, Tengyi Cai, Delphine Borgel, Dominique Lasne, Sylvain Renolleau, Meryl Vedrenne-Cloquet, et al. (+12)
565 [GO] 2022―Apr―29 Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England T. Beaney, A. L. Neves, A. Alboksmaty, H. Ashrafian, K. Flott, A. Fowler, et al. (+5)
566 [GO] 2022―Apr―28 An energizing role for motivation in information-seeking during the early phase of the COVID-19 pandemic Yaniv Abir, Caroline B. Marvin, Camilla van Geen, Maya Leshkowitz, Ran R. Hassin, Daphna Shohamy
567 [GO] 2022―Apr―28 Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes Raffaele Marfella, Celestino Sardu, Nunzia D’Onofrio, Francesco Prattichizzo, Lucia Scisciola, Vincenzo Messina, et al. (+6)
568 [GO] 2022―Apr―27 Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease Daniel W. Kneller, Hui Li, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Mark A. Arnould, et al. (+8)
569 [GO] 2022―Apr―25 Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2 Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, et al. (+13)
570 [GO] 2022―Apr―22 Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel Jacob G. Waxman, Maya Makov-Assif, Ben Y. Reis, Doron Netzer, Ran D. Balicer, Noa Dagan, Noam Barda
571 [GO] 2022―Apr―21 App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden Beatrice Kennedy, Hugo Fitipaldi, Ulf Hammar, Marlena Maziarz, Neli Tsereteli, Nikolay Oskolkov, et al. (+30)
572 [GO] 2022―Apr―19 Accelerated biological aging in COVID-19 patients Xue Cao, Wenjuan Li, Ting Wang, Dongzhi Ran, Veronica Davalos, Laura Planas-Serra, et al. (+4)
573 [GO] 2022―Apr―19 Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model Qizhou Lian, Kui Zhang, Zhao Zhang, Fuyu Duan, Liyan Guo, Weiren Luo, et al. (+26)
574 [GO] 2022―Apr―13 Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventions Simon Arsène, Claire Couty, Igor Faddeenkov, Natacha Go, Solène Granjeon-Noriot, Daniel Šmít, et al. (+7)
575 [GO] 2022―Apr―12 Persistent COVID-19 symptoms in a community study of 606,434 people in England Matthew Whitaker, Joshua Elliott, Marc Chadeau-Hyam, Steven Riley, Ara Darzi, Graham Cooke, et al. (+2)
576 [GO] 2022―Apr―12 Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events Rachael Pung, Josh A. Firth, Lewis G. Spurgin, Annie Chang, Jade Kong, Jazzy Wong, et al. (+54)
577 [GO] 2022―Apr―12 Author Correction: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies Fortunato Ferrara, M. Frank Erasmus, Sara D’Angelo, Camila Leal-Lopes, André A. Teixeira, Alok Choudhary, et al. (+9)
578 [GO] 2022―Apr―08 Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage Cathrine Scheepers, Josie Everatt, Daniel G. Amoako, Houriiyah Tegally, Constantinos Kurt Wibmer, Anele Mnguni, et al. (+39)
579 [GO] 2022―Apr―07 Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19 Hengrui Liu, Sho Iketani, Arie Zask, Nisha Khanizeman, Eva Bednarova, Farhad Forouhar, et al. (+26)
580 [GO] 2022―Apr―06 Author Correction: National identity predicts public health support during a global pandemic Jay J. Van Bavel, Aleksandra Cichocka, Valerio Capraro, Hallgeir Sjåstad, John B. Nezlek, Tomislav Pavlović, et al. (+251)
581 [GO] 2022―Apr―05 Group testing via hypergraph factorization applied to COVID-19 David Hong, Rounak Dey, Xihong Lin, Brian Cleary, Edgar Dobriban
582 [GO] 2022―Apr―05 Black carbon-climate interactions regulate dust burdens over India revealed during COVID-19 Linyi Wei, Zheng Lu, Yong Wang, Xiaohong Liu, Weiyi Wang, Chenglai Wu, et al. (+4)
583 [GO] 2022―Apr―05 Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort Viet-Thi Tran, Raphaël Porcher, Isabelle Pane, Philippe Ravaud
584 [GO] 2022―Apr―04 Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern Xiaoqi Yu, Dong Wei, Wenxin Xu, Chuanmiao Liu, Wentian Guo, Xinxin Li, et al. (+6)
585 [GO] 2022―Apr―01 Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates Ibolya Rutkai, Meredith G. Mayer, Linh M. Hellmers, Bo Ning, Zhen Huang, Christopher J. Monjure, et al. (+16)
586 [GO] 2022―Mar―31 Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination Vijaykrishna Dhanasekaran, Sheena Sullivan, Kimberly M. Edwards, Ruopeng Xie, Arseniy Khvorov, Sophie A. Valkenburg, et al. (+2)
587 [GO] 2022―Mar―31 Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G. Anosova, Dean Huang, Tim Tibbitts, et al. (+6)
588 [GO] 2022―Mar―30 Publisher Correction: Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater Davida S. Smyth, Monica Trujillo, Devon A. Gregory, Kristen Cheung, Anna Gao, Maddie Graham, et al. (+16)
589 [GO] 2022―Mar―28 Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617 Lei Peng, Yingxia Hu, Madeleine C. Mankowski, Ping Ren, Rita E. Chen, Jin Wei, et al. (+18)
590 [GO] 2022―Mar―28 Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors Laura Pérez-Alós, Jose Juan Almagro Armenteros, Johannes Roth Madsen, Cecilie Bo Hansen, Ida Jarlhelt, Sebastian Rask Hamm, et al. (+17)
591 [GO] 2022―Mar―25 Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19 Tanja Paul, Stephan Ledderose, Harald Bartsch, Na Sun, Sarah Soliman, Bruno Märkl, et al. (+18)
592 [GO] 2022―Mar―25 Author Correction: Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom Long H. Nguyen, Amit D. Joshi, David A. Drew, Jordi Merino, Wenjie Ma, Chun-Han Lo, et al. (+19)
593 [GO] 2022―Mar―25 Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium Andreia L. Pinto, Ranjit K. Rai, Jonathan C. Brown, Paul Griffin, James R. Edgar, Anand Shah, et al. (+5)
594 [GO] 2022―Mar―25 MERS-CoV ORF4b employs an unusual binding mechanism to target IMPα and block innate immunity Thilini S. Munasinghe, Megan R. Edwards, Sofiya Tsimbalyuk, Olivia A. Vogel, Kate M. Smith, Murray Stewart, et al. (+6)
595 [GO] 2022―Mar―21 Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50 Junqing Xie, Shuo Feng, Xintong Li, Ester Gea-Mallorquí, Albert Prats-Uribe, Dani Prieto-Alhambra
596 [GO] 2022―Mar―17 Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 Benjamin Faucher, Rania Assab, Jonathan Roux, Daniel Levy-Bruhl, Cécile Tran Kiem, Simon Cauchemez, et al. (+4)
597 [GO] 2022―Mar―17 RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection Geng Liu, Wenya Du, Xiongbo Sang, Qiyu Tong, Ye Wang, Guoqing Chen, et al. (+6)
598 [GO] 2022―Mar―17 De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report Shiv Gandhi, Jonathan Klein, Alexander J. Robertson, Mario A. Peña-Hernández, Michelle J. Lin, Pavitra Roychoudhury, et al. (+17)
599 [GO] 2022―Mar―16 Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin, Diana Muñoz Sandoval, Catherine J. Reynolds, Rocio Castro Seoane, et al. (+564)
600 [GO] 2022―Mar―11 Publisher Correction: Abrupt emissions reductions during COVID-19 contributed to record summer rainfall in China Yang Yang, Lili Ren, Mingxuan Wu, Hailong Wang, Fengfei Song, L. Ruby Leung, et al. (+10)
601 [GO] 2022―Mar―10 Divergent trajectories of antiviral memory after SARS-CoV-2 infection Adriana Tomic, Donal T. Skelly, Ane Ogbe, Daniel O’Connor, Matthew Pace, Emily Adland, et al. (+102)
602 [GO] 2022―Mar―09 Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity Otavio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, et al. (+30)
603 [GO] 2022―Mar―04 COVID-19, Green Deal and recovery plan permanently change emissions and prices in EU ETS Phase IV Kenneth Bruninx, Marten Ovaere
604 [GO] 2022―Mar―04 The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers’ unvaccinated household members Jussipekka Salo, Milla Hägg, Mika Kortelainen, Tuija Leino, Tanja Saxell, Markku Siikanen, Lauri Sääksvuori
605 [GO] 2022―Mar―04 Waning of SARS-CoV-2 booster viral-load reduction effectiveness Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Esma Herzel, Jacob Kuint, Gabriel Chodick, et al. (+3)
606 [GO] 2022―Mar―04 Evolution of the SARS-CoV-2 spike protein in the human host Antoni G. Wrobel, Donald J. Benton, Chloë Roustan, Annabel Borg, Saira Hussain, Stephen R. Martin, et al. (+3)
607 [GO] 2022―Mar―03 Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmission Yun Lin, Bingyi Yang, Sarah Cobey, Eric H. Y. Lau, Dillon C. Adam, Jessica Y. Wong, et al. (+10)
608 [GO] 2022―Mar―03 Antibody escape and global spread of SARS-CoV-2 lineage A.27 Tamara Kaleta, Lisa Kern, Samuel Leandro Hong, Martin Hölzer, Georg Kochs, Julius Beer, et al. (+27)
609 [GO] 2022―Mar―03 Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain Gang Ye, Bin Liu, Fang Li
610 [GO] 2022―Mar―02 Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells Tammy C. T. Lan, Matty F. Allan, Lauren E. Malsick, Jia Z. Woo, Chi Zhu, Fengrui Zhang, et al. (+8)
611 [GO] 2022―Mar―01 Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools Trystan Leng, Edward M. Hill, Alex Holmes, Emma Southall, Robin N. Thompson, Michael J. Tildesley, et al. (+2)
612 [GO] 2022―Feb―28 Population-scale dietary interests during the COVID-19 pandemic Kristina Gligorić, Arnaud Chiolero, Emre Kıcıman, Ryen W. White, Robert West
613 [GO] 2022―Feb―23 Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission Dinesh Aggarwal, Andrew J. Page, Ulf Schaefer, George M. Savva, Richard Myers, Erik Volz, et al. (+599)
614 [GO] 2022―Feb―23 Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection Kami Pekayvaz, Alexander Leunig, Rainer Kaiser, Markus Joppich, Sophia Brambs, Aleksandar Janjic, et al. (+38)
615 [GO] 2022―Feb―22 Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core Alexander J. Pak, Alvin Yu, Zunlong Ke, John A. G. Briggs, Gregory A. Voth
616 [GO] 2022―Feb―18 Abrupt emissions reductions during COVID-19 contributed to record summer rainfall in China Yang Yang, Lili Ren, Mingxuan Wu, Hailong Wang, Fengfei Song, L. Ruby Leung, et al. (+10)
617 [GO] 2022―Feb―17 Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications Maryam A. Y. Al-Nesf, Houari B. Abdesselem, Ilham Bensmail, Shahd Ibrahim, Walaa A. H. Saeed, Sara S. I. Mohammed, et al. (+20)
618 [GO] 2022―Feb―17 Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning Yvonne M. Mueller, Thijs J. Schrama, Rik Ruijten, Marco W. J. Schreurs, Dwin G. B. Grashof, Harmen J. G. van de Werken, et al. (+22)
619 [GO] 2022―Feb―17 Publisher Correction: Characterising within-hospital SARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves Benjamin B. Lindsey, Ch. Julián Villabona-Arenas, Finlay Campbell, Alexander J. Keeley, Matthew D. Parker, Dhruv R. Shah, et al. (+51)
620 [GO] 2022―Feb―16 Population antibody responses following COVID-19 vaccination in 212,102 individuals Helen Ward, Matthew Whitaker, Barnaby Flower, Sonja N. Tang, Christina Atchison, Ara Darzi, et al. (+8)
621 [GO] 2022―Feb―15 Cell specific peripheral immune responses predict survival in critical COVID-19 patients Junedh M. Amrute, Alexandra M. Perry, Gautam Anand, Carlos Cruchaga, Karl G. Hock, Christopher W. Farnsworth, et al. (+3)
622 [GO] 2022―Feb―15 Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies Yifan Wang, Caixuan Liu, Chao Zhang, Yanxing Wang, Qin Hong, Shiqi Xu, et al. (+4)
623 [GO] 2022―Feb―15 The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern Rana Abdelnabi, Caroline S. Foo, Dirk Jochmans, Laura Vangeel, Steven De Jonghe, Patrick Augustijns, et al. (+11)
624 [GO] 2022―Feb―14 AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic Tuyet Hoang, Anders Gonçalves da Silva, Amy V. Jennison, Deborah A. Williamson, Benjamin P. Howden, Torsten Seemann
625 [GO] 2022―Feb―14 Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies Daniel Re, Barbara Seitz-Polski, Vesna Brglez, Michel Carles, Daisy Graça, Sylvia Benzaken, et al. (+7)
626 [GO] 2022―Feb―14 Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein Oskar Staufer, Kapil Gupta, Jochen Estebano Hernandez Bücher, Fabian Kohler, Christian Sigl, Gunjita Singh, et al. (+11)
627 [GO] 2022―Feb―09 Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection Jing Zou, Hongjie Xia, Xuping Xie, Chaitanya Kurhade, Rafael R. G. Machado, Scott C. Weaver, et al. (+2)
628 [GO] 2022―Feb―08 Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission Dinesh Aggarwal, Ben Warne, Aminu S. Jahun, William L. Hamilton, Thomas Fieldman, Louis du Plessis, et al. (+722)
629 [GO] 2022―Feb―08 Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong Haogao Gu, Ruopeng Xie, Dillon C. Adam, Joseph L.-H. Tsui, Daniel K. Chu, Lydia D. J. Chang, et al. (+17)
630 [GO] 2022―Feb―08 Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants James W. Saville, Dhiraj Mannar, Xing Zhu, Shanti S. Srivastava, Alison M. Berezuk, Jean-Philippe Demers, et al. (+7)
631 [GO] 2022―Feb―03 Myeloid cell interferon responses correlate with clearance of SARS-CoV-2 Dhiraj K. Singh, Ekaterina Aladyeva, Shibali Das, Bindu Singh, Ekaterina Esaulova, Amanda Swain, et al. (+8)
632 [GO] 2022―Feb―03 Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater Davida S. Smyth, Monica Trujillo, Devon A. Gregory, Kristen Cheung, Anna Gao, Maddie Graham, et al. (+16)
633 [GO] 2022―Feb―03 Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria Egon A. Ozer, Lacy M. Simons, Olubusuyi M. Adewumi, Adeola A. Fowotade, Ewean C. Omoruyi, Johnson A. Adeniji, et al. (+14)
634 [GO] 2022―Feb―03 Characterising within-hospitalSARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves Benjamin B. Lindsey, Ch. Julián Villabona-Arenas, Finlay Campbell, Alexander J. Keeley, Matthew D. Parker, Dhruv R. Shah, et al. (+51)
635 [GO] 2022―Feb―02 A population-based cohort study of obesity, ethnicity and COVID-19 mortality in 12.6 million adults in England Thomas Yates, Annabel Summerfield, Cameron Razieh, Amitava Banerjee, Yogini Chudasama, Melanie J. Davies, et al. (+7)
636 [GO] 2022―Feb―02 Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England Gayatri Amirthalingam, Jamie Lopez Bernal, Nick J. Andrews, Heather Whitaker, Charlotte Gower, Julia Stowe, et al. (+12)
637 [GO] 2022―Feb―02 A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase Ashleigh Shannon, Véronique Fattorini, Bhawna Sama, Barbara Selisko, Mikael Feracci, Camille Falcou, et al. (+17)
638 [GO] 2022―Feb―01 Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom Long H. Nguyen, Amit D. Joshi, David A. Drew, Jordi Merino, Wenjie Ma, Chun-Han Lo, et al. (+19)
639 [GO] 2022―Feb―01 Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico Ana Basto-Abreu, Martha Carnalla, Leticia Torres-Ibarra, Martín Romero-Martínez, Jesús Martínez-Barnetche, Irma López-Martínez, et al. (+19)
640 [GO] 2022―Feb―01 SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load Tobias Mourier, Muhammad Shuaib, Sharif Hala, Sara Mfarrej, Fadwa Alofi, Raeece Naeem, et al. (+30)
641 [GO] 2022―Feb―01 Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot Jörg Paetzold, Janine Kimpel, Katie Bates, Michael Hummer, Florian Krammer, Dorothee von Laer, Hannes Winner
642 [GO] 2022―Jan―27 Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools using agent-based simulations and cluster tracing data Jana Lasser, Johannes Sorger, Lukas Richter, Stefan Thurner, Daniela Schmid, Peter Klimek
643 [GO] 2022―Jan―27 Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections Laith J. Abu-Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, Peter Coyle, Mohammad R. Hasan, et al. (+17)
644 [GO] 2022―Jan―26 National identity predicts public health support during a global pandemic Jay J. Van Bavel, Aleksandra Cichocka, Valerio Capraro, Hallgeir Sjåstad, John B. Nezlek, Tomislav Pavlović, et al. (+251)
645 [GO] 2022―Jan―25 Regional excess mortality during the 2020 COVID-19 pandemic in five European countries Garyfallos Konstantinoudis, Michela Cameletti, Virgilio Gómez-Rubio, Inmaculada León Gómez, Monica Pirani, Gianluca Baio, et al. (+5)
646 [GO] 2022―Jan―25 Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Tala Ballouz, Dominik Menges, Sara Hasler, et al. (+10)
647 [GO] 2022―Jan―24 Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant Baisheng Li, Aiping Deng, Kuibiao Li, Yao Hu, Zhencui Li, Yaling Shi, et al. (+40)
648 [GO] 2022―Jan―24 A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies Fortunato Ferrara, M. Frank Erasmus, Sara D’Angelo, Camila Leal-Lopes, André A. Teixeira, Alok Choudhary, et al. (+9)
649 [GO] 2022―Jan―21 Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19 Avraham Unterman, Tomokazu S. Sumida, Nima Nouri, Xiting Yan, Amy Y. Zhao, Victor Gasque, et al. (+46)
650 [GO] 2022―Jan―21 Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response time Claudia E. Vickers, Paul S. Freemont
651 [GO] 2022―Jan―20 Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong Francisco Tsz Tsun Lai, Lei Huang, Celine Sze Ling Chui, Eric Yuk Fai Wan, Xue Li, Carlos King Ho Wong, et al. (+7)
652 [GO] 2022―Jan―20 Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2 Lamiaa El-Shennawy, Andrew D. Hoffmann, Nurmaa Khund Dashzeveg, Kathleen M. McAndrews, Paul J. Mehl, Daphne Cornish, et al. (+30)
653 [GO] 2022―Jan―19 A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, et al. (+32)
654 [GO] 2022―Jan―18 Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2 Valeria Garcia-Flores, Roberto Romero, Yi Xu, Kevin R. Theis, Marcia Arenas-Hernandez, Derek Miller, et al. (+18)
655 [GO] 2022―Jan―14 Model-based evaluation of alternative reactive class closure strategies against COVID-19 Quan-Hui Liu, Juanjuan Zhang, Cheng Peng, Maria Litvinova, Shudong Huang, Piero Poletti, et al. (+11)
656 [GO] 2022―Jan―12 Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation Haibo Wu, Peiqi He, Yong Ren, Shiqi Xiao, Wei Wang, Zhenbang Liu, et al. (+17)
657 [GO] 2022―Jan―11 Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2 Kapil Gupta, Christine Toelzer, Maia Kavanagh Williamson, Deborah K. Shoemark, A. Sofia F. Oliveira, David A. Matthews, et al. (+11)
658 [GO] 2022―Jan―11 Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk David R. M. Smith, Audrey Duval, Jean Ralph Zahar, Niels Hendrickx, Kévin Jean, Sofía Jijón, et al. (+5)
659 [GO] 2022―Jan―11 Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies Jeremy R. Keown, Zihan Zhu, Loïc Carrique, Haitian Fan, Alexander P. Walker, Itziar Serna Martin, et al. (+4)
660 [GO] 2022―Jan―10 Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges João Faro-Viana, Marie-Louise Bergman, Lígia A. Gonçalves, Nádia Duarte, Teresa P. Coutinho, Patrícia C. Borges, et al. (+14)
661 [GO] 2022―Jan―10 Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts Rhia Kundu, Janakan Sam Narean, Lulu Wang, Joseph Fenn, Timesh Pillay, Nieves Derqui Fernandez, et al. (+17)
662 [GO] 2022―Jan―10 Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Nina Koerber, Alina Priller, Sarah Yazici, Tanja Bauer, Cho-Chin Cheng, Hrvoje Mijočević, et al. (+19)
663 [GO] 2022―Jan―10 A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo Leo Hanke, Hrishikesh Das, Daniel J. Sheward, Laura Perez Vidakovics, Egon Urgard, Ainhoa Moliner-Morro, et al. (+12)
664 [GO] 2022―Jan―10 Robust and durable serological response following pediatric SARS-CoV-2 infection Hanna Renk, Alex Dulovic, Alina Seidel, Matthias Becker, Dorit Fabricius, Maria Zernickel, et al. (+44)
665 [GO] 2022―Jan―10 Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets Young-Il Kim, Kwang-Min Yu, June-Young Koh, Eun-Ha Kim, Se-Mi Kim, Eun Ji Kim, et al. (+15)
666 [GO] 2022―Jan―10 Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors Daichao Wu, Alexander Kolesnikov, Rui Yin, Johnathan D. Guest, Ragul Gowthaman, Anton Shmelev, et al. (+5)
667 [GO] 2021―Dec―20 Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM Yifan Wang, Cong Xu, Yanxing Wang, Qin Hong, Chao Zhang, Zuyang Li, et al. (+5)
668 [GO] 2021―Dec―16 Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography Obinna C. Ubah, Eric W. Lake, Gihan S. Gunaratne, Joseph P. Gallant, Marie Fernie, Austin J. Robertson, et al. (+15)
669 [GO] 2021―Dec―16 Author Correction: Development of a model-inference system for estimating epidemiological characteristics of SARS-CoV-2 variants of concern Wan Yang, Jeffrey Shaman
670 [GO] 2021―Dec―14 The effect of COVID-19 vaccination in Italy and perspectives for living with the virus Valentina Marziano, Giorgio Guzzetta, Alessia Mammone, Flavia Riccardo, Piero Poletti, Filippo Trentini, et al. (+9)
671 [GO] 2021―Dec―14 A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults Miwa Haranaka, James Baber, Yoichiro Ogama, Masako Yamaji, Masakazu Aizawa, Osamu Kogawara, et al. (+7)
672 [GO] 2021―Dec―14 Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation Keisuke Tabata, Vibhu Prasad, David Paul, Ji-Young Lee, Minh-Tu Pham, Woan-Ing Twu, et al. (+20)
673 [GO] 2021―Dec―14 Estimating the strength of selection for new SARS-CoV-2 variants Christiaan H. van Dorp, Emma E. Goldberg, Nick Hengartner, Ruian Ke, Ethan O. Romero-Severson
674 [GO] 2021―Dec―13 Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load Frederik Plesner Lyngse, Kåre Mølbak, Robert Leo Skov, Lasse Engbo Christiansen, Laust Hvas Mortensen, Mads Albertsen, et al. (+105)
675 [GO] 2021―Dec―10 Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England Gayatri Amirthalingam, Jamie Lopez Bernal, Nick J. Andrews, Heather Whitaker, Charlotte Gower, Julia Stowe, et al. (+12)
676 [GO] 2021―Dec―10 The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting Matthias M. Zimmer, Anuja Kibe, Ulfert Rand, Lukas Pekarek, Liqing Ye, Stefan Buck, et al. (+3)
677 [GO] 2021―Dec―09 Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19 Masako Nishikawa, Hiroshi Kanno, Yuqi Zhou, Ting-Hui Xiao, Takuma Suzuki, Yuma Ibayashi, et al. (+18)
678 [GO] 2021―Dec―07 Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 Catherine F. Hatton, Rachel A. Botting, Maria Emilia Dueñas, Iram J. Haq, Bernard Verdon, Benjamin J. Thompson, et al. (+22)
679 [GO] 2021―Dec―03 Modeling serological testing to inform relaxation of social distancing for COVID-19 control Alicia N. M. Kraay, Kristin N. Nelson, Conan Y. Zhao, David Demory, Joshua S. Weitz, Benjamin A. Lopman
680 [GO] 2021―Dec―01 Publisher Correction: Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA Aravind Natarajan, Alvin Han, Soumaya Zlitni, Erin F. Brooks, Summer E. Vance, Marlene Wolfe, et al. (+5)
681 [GO] 2021―Nov―30 Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants Melanie Koehler, Ankita Ray, Rodrigo A. Moreira, Blinera Juniku, Adolfo B. Poma, David Alsteens
682 [GO] 2021―Nov―26 Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic Meng-Jie Geng, Hai-Yang Zhang, Lin-Jie Yu, Chen-Long Lv, Tao Wang, Tian-Le Che, et al. (+10)
683 [GO] 2021―Nov―26 Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization Dennis Lapuente, Jana Fuchs, Jonas Willar, Ana Vieira Antão, Valentina Eberlein, Nadja Uhlig, et al. (+17)
684 [GO] 2021―Nov―25 Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response Jonathan D. Herman, Chuangqi Wang, Carolin Loos, Hyunah Yoon, Johanna Rivera, M. Eugenia Dieterle, et al. (+9)
685 [GO] 2021―Nov―25 Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses Tiago Fazolo, Karina Lima, Julia C. Fontoura, Priscila Oliveira de Souza, Gabriel Hilario, Renata Zorzetto, et al. (+25)
686 [GO] 2021―Nov―25 Spike residue 403 affects binding of coronavirus spikes to human ACE2 Fabian Zech, Daniel Schniertshauer, Christoph Jung, Alexandra Herrmann, Arne Cordsmeier, Qinya Xie, et al. (+16)
687 [GO] 2021―Nov―25 SARS-CoV-2 transmission across age groups in France and implications for control Cécile Tran Kiem, Paolo Bosetti, Juliette Paireau, Pascal Crépey, Henrik Salje, Noémie Lefrancq, et al. (+6)
688 [GO] 2021―Nov―23 Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands Lu Lu, Reina S. Sikkema, Francisca C. Velkers, David F. Nieuwenhuijse, Egil A. J. Fischer, Paola A. Meijer, et al. (+18)
689 [GO] 2021―Nov―23 ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury Tomokazu Yamaguchi, Midori Hoshizaki, Takafumi Minato, Satoru Nirasawa, Masamitsu N. Asaka, Mayumi Niiyama, et al. (+24)
690 [GO] 2021―Nov―19 COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types Benjamin J. Schmiedel, Job Rocha, Cristian Gonzalez-Colin, Sourya Bhattacharyya, Ariel Madrigal, Christian H. Ottensmeier, et al. (+3)
691 [GO] 2021―Nov―19 Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities Thomas Kruse, Caroline Benz, Dimitriya H. Garvanska, Richard Lindqvist, Filip Mihalic, Fabian Coscia, et al. (+16)
692 [GO] 2021―Nov―18 Jumper enables discontinuous transcript assembly in coronaviruses Palash Sashittal, Chuanyi Zhang, Jian Peng, Mohammed El-Kebir
693 [GO] 2021―Nov―18 Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity Irene A. Abela, Chloé Pasin, Magdalena Schwarzmüller, Selina Epp, Michèle E. Sickmann, Merle M. Schanz, et al. (+25)
694 [GO] 2021―Nov―16 Organ-specific genome diversity of replication-competent SARS-CoV-2 Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, Amélie Dendooven, Valentino D’Onofrio, Liesbeth Couck, et al. (+17)
695 [GO] 2021―Nov―16 SARS-CoV-2 infection and replication in human gastric organoids Giovanni Giuseppe Giobbe, Francesco Bonfante, Brendan C. Jones, Onelia Gagliano, Camilla Luni, Elisa Zambaiti, et al. (+19)
696 [GO] 2021―Nov―15 SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis Ji-Seung Yoo, Michihito Sasaki, Steven X. Cho, Yusuke Kasuga, Baohui Zhu, Ryota Ouda, et al. (+4)
697 [GO] 2021―Nov―12 Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status Yan Xie, Benjamin Bowe, Ziyad Al-Aly
698 [GO] 2021―Nov―12 SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains Peter Radvak, Hyung-Joon Kwon, Martina Kosikova, Uriel Ortega-Rodriguez, Ruoxuan Xiang, Je-Nie Phue, et al. (+6)
699 [GO] 2021―Nov―11 Diverse integrated ecosystem approach overcomes pandemic-related fisheries monitoring challenges Jarrod A. Santora, Tanya L. Rogers, Megan A. Cimino, Keith M. Sakuma, Keith D. Hanson, E. J. Dick, et al. (+3)
700 [GO] 2021―Nov―09 A novel SARS-CoV-2 related coronavirus in bats from Cambodia Deborah Delaune, Vibol Hul, Erik A. Karlsson, Alexandre Hassanin, Tey Putita Ou, Artem Baidaliuk, et al. (+12)
701 [GO] 2021―Nov―08 Spatiotemporal prediction of COVID-19 cases using inter- and intra-county proxies of human interactions Behzad Vahedi, Morteza Karimzadeh, Hamidreza Zoraghein
702 [GO] 2021―Nov―05 Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets Robert M. Cox, Josef D. Wolf, Carolin M. Lieber, Julien Sourimant, Michelle J. Lin, Darius Babusis, et al. (+13)
703 [GO] 2021―Nov―04 Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants Sebastian Weigang, Jonas Fuchs, Gert Zimmer, Daniel Schnepf, Lisa Kern, Julius Beer, et al. (+17)
704 [GO] 2021―Nov―04 Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine Barak Mizrahi, Roni Lotan, Nir Kalkstein, Asaf Peretz, Galit Perez, Amir Ben-Tov, et al. (+3)
705 [GO] 2021―Nov―04 Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine Ricardo Aguas, Anouska Bharath, Lisa J. White, Bo Gao, Andrew J. Pollard, Merryn Voysey, Rima Shretta
706 [GO] 2021―Nov―02 Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants Tingting Li, Xiaojian Han, Chenjian Gu, Hangtian Guo, Huajun Zhang, Yingming Wang, et al. (+40)
707 [GO] 2021―Nov―01 A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters Phanramphoei N. Frantz, Aleksandr Barinov, Claude Ruffié, Chantal Combredet, Valérie Najburg, Guilherme Dias de Melo, et al. (+18)
708 [GO] 2021―Nov―01 Understanding how Victoria, Australia gained control of its second COVID-19 wave James M. Trauer, Michael J. Lydeamore, Gregory W. Dalton, David Pilcher, Michael T. Meehan, Emma S. McBryde, et al. (+3)
709 [GO] 2021―Oct―29 Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host Verónica Lloréns-Rico, Ann C. Gregory, Johan Van Weyenbergh, Sander Jansen, Tina Van Buyten, Junbin Qian, et al. (+21)
710 [GO] 2021―Oct―29 Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa Krishna P. Reddy, Kieran P. Fitzmaurice, Justine A. Scott, Guy Harling, Richard J. Lessells, Christopher Panella, et al. (+3)
711 [GO] 2021―Oct―29 Anti-spike antibody response to natural SARS-CoV-2 infection in the general population Jia Wei, Philippa C. Matthews, Nicole Stoesser, Thomas Maddox, Luke Lorenzi, Ruth Studley, et al. (+74)
712 [GO] 2021―Oct―28 Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo Matt D. T. Hitchings, Otavio T. Ranzani, Murilo Dorion, Tatiana Lang D’Agostini, Regiane Cardoso de Paula, Olivia Ferreira Pereira de Paula, et al. (+14)
713 [GO] 2021―Oct―28 A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries Francesco Sera, Ben Armstrong, Sam Abbott, Sophie Meakin, Kathleen O’Reilly, Rosa von Borries, et al. (+92)
714 [GO] 2021―Oct―27 A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses Weina Sun, Yonghong Liu, Fatima Amanat, Irene González-Domínguez, Stephen McCroskery, Stefan Slamanig, et al. (+19)
715 [GO] 2021―Oct―26 Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels C. Bottomley, M. Otiende, S. Uyoga, K. Gallagher, E. W. Kagucia, A. O. Etyang, et al. (+9)
716 [GO] 2021―Oct―26 Potentially long-lasting effects of the pandemic on scientists Jian Gao, Yian Yin, Kyle R. Myers, Karim R. Lakhani, Dashun Wang
717 [GO] 2021―Oct―20 COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, Romain Marlin, Nathalie Dereuddre-Bosquet, Natalia A. Kuzmina, et al. (+45)
718 [GO] 2021―Oct―20 Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants Pengcheng Han, Chao Su, Yanfang Zhang, Chongzhi Bai, Anqi Zheng, Chengpeng Qiao, et al. (+18)
719 [GO] 2021―Oct―18 Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 Britton Boras, Rhys M. Jones, Brandon J. Anson, Dan Arenson, Lisa Aschenbrenner, Malina A. Bakowski, et al. (+46)
720 [GO] 2021―Oct―15